1	Th	NN	O	th	npadvmod	19	SENT_1	[p1l672t81r703b102],
2	e	SYM	O	e	dep	11	SENT_1	[p1l709t88r717b102],
3	N	NN	O	n	nn	11	SENT_1	[p1l735t83r759b102],
4	E	NN	O	e	nn	11	SENT_1	[p1l767t83r784b102],
5	W	NN	O	w	nn	11	SENT_1	[p1l790t83r821b102],
6	E	NN	O	e	nn	11	SENT_1	[p1l840t83r857b102],
7	N	NN	O	n	nn	11	SENT_1	[p1l865t83r888b102],
8	G	NN	O	g	nn	11	SENT_1	[p1l895t83r917b102],
9	L	NN	O	l	nn	11	SENT_1	[p1l924t83r941b102],
10	A	NN	O	a	nn	11	SENT_1	[p1l947t83r968b102],
11	ND	NN	O	nd	dep	1	SENT_1	[p1l975t83r1060b109],
12	]	CD	NUMBER	]	num	13	SENT_1	[p1l975t83r1060b109],
13	O	NN	O	o	dep	11	SENT_1	[p1l1066t83r1088b102],
14	U	NNP	O	U	nn	18	SENT_1	[p1l1095t83r1117b102],
15	R	NNP	O	R	nn	18	SENT_1	[p1l1125t83r1146b102],
16	N	NNP	O	N	nn	18	SENT_1	[p1l1153t83r1177b102],
17	A	NNP	O	A	nn	18	SENT_1	[p1l1183t83r1203b102],
18	L	NN	O	l	dep	13	SENT_1	[p1l1211t83r1227b102],
19	of	IN	O	of	dep	23	SENT_1	[p1l1247t81r1275b108],
20	M	NN	O	m	nn	22	SENT_1	[p1l1287t83r1314b102],
21	E	NN	O	e	nn	22	SENT_1	[p1l1322t83r1339b102],
22	D	NN	O	d	pobj	19	SENT_1	[p1l1347t83r1369b102],
23	I	PRP	O	I	_	0	SENT_1	[p1l1376t83r1386b102],
24	C	NN	O	c	prep	23	SENT_1	[p1l1393t83r1411b102],
25	I	PRP	O	I	dep	26	SENT_1	[p1l1419t83r1429b102],
26	NE	NNS	O	ne	dep	24	SENT_1	[p1l1438t83r1487b102],

1	|	JJ	O	|	amod	2	SENT_2	[p1l235t184r238b385],
2	EDITORIAL	NN	O	editorial	_	0	SENT_2	[p1l894t257r1268b290],
3	|	IN	O	|	dep	2	SENT_2	[p1l1921t184r1924b385],

1	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	3	SENT_3	[p1l474t620r995b684],
2	—	NNP	O	—	nn	3	SENT_3	[p1l1012t650r1077b656],
3	Ready	NNP	O	Ready	_	0	SENT_3	[p1l1097t620r1252b684],
4	for	IN	O	for	_	0	SENT_3	[p1l1268t620r1342b669],
5	Prime	NNP	O	Prime	nn	6	SENT_3	[p1l1362t622r1513b669],
6	Time	NNP	O	Time	prep_for	3	SENT_3	[p1l1529t620r1689b669],
7	?	.	O	?	_	0	SENT_3	[p1l1529t620r1689b669],

1	Susan	NNP	PERSON	Susan	nn	3	SENT_4	[p1l622t704r722b733],
2	B.	NNP	PERSON	B.	nn	3	SENT_4	[p1l742t705r769b733],
3	Shurin	NNP	PERSON	Shurin	_	0	SENT_4	[p1l786t702r905b739],
4	,	,	O	,	_	0	SENT_4	[p1l786t702r905b739],
5	M.D.	NNP	O	M.D.	conj_and	3	SENT_4	[p1l924t705r1014b739],
6	,	,	O	,	_	0	SENT_4	[p1l924t705r1014b739],
7	and	CC	O	and	_	0	SENT_4	[p1l1031t702r1091b733],
8	Elizabeth	NNP	PERSON	Elizabeth	nn	12	SENT_4	[p1l1110t702r1261b733],
9	G.	NNP	PERSON	G.	nn	12	SENT_4	[p1l1277t704r1312b733],
10	Nabel	NNP	PERSON	Nabel	nn	12	SENT_4	[p1l1331t702r1437b739],
11	,	,	O	,	_	0	SENT_4	[p1l1331t702r1437b739],
12	M.D.	NNP	O	M.D.	conj_and	3	SENT_4	[p1l1456t705r1536b733],

1	It	PRP	O	it	nsubjpass	5	SENT_5	[p1l135t925r203b996],
2	can	MD	O	can	aux	5	SENT_5	[p1l238t934r536b996],
3	not	RB	O	not	neg	5	SENT_5	[p1l238t934r536b996],
4	be	VB	O	be	auxpass	5	SENT_5	[p1l572t917r669b996],
5	emphasized	VBN	O	emphasize	_	0	SENT_5	[p1l711t917r1230b1018],
6	too	RB	O	too	advmod	7	SENT_5	[p1l1271t934r1407b996],
7	strongly	RB	O	strongly	advmod	5	SENT_5	[p1l1449t917r1805b1018],
8	that	IN	O	that	dep	17	SENT_5	[p1l1841t917r2011b996],
9	treatment	NN	O	treatment	nsubj	17	SENT_5	[p1l138t1062r544b1124],
10	of	IN	O	of	_	0	SENT_5	[p1l572t1045r672b1124],
11	each	DT	O	each	det	12	SENT_5	[p1l687t1045r874b1124],
12	patient	NN	O	patient	prep_of	9	SENT_5	[p1l905t1046r1198b1146],
13	is	VBZ	O	be	cop	17	SENT_5	[p1l1224t1046r1289b1124],
14	a	DT	O	a	det	17	SENT_5	[p1l1323t1072r1367b1124],
15	highly	RB	O	highly	advmod	16	SENT_5	[p1l1399t1045r1661b1146],
16	individualized	JJ	O	individualized	amod	17	SENT_5	[p1l1688t1045r2004b1124, p1l137t1174r446b1253],
17	matter	NN	O	matter	ccomp	7	SENT_5	[p1l482t1191r787b1253],
18	.	.	O	.	_	0	SENT_5	[p1l482t1191r787b1253],

1	—	NN	O	—	nsubj	4	SENT_6	[p1l298t1477r406b1485],
2	FDA	NNP	O	FDA	dep	1	SENT_6	[p1l437t1432r1064b1533],
3	—	CD	NUMBER	—	num	2	SENT_6	[p1l437t1432r1064b1533],
4	approved	VBD	O	approve	_	0	SENT_6	[p1l437t1432r1064b1533],
5	labeling	NN	O	labeling	dobj	4	SENT_6	[p1l1100t1432r1451b1533],
6	for	IN	O	for	_	0	SENT_6	[p1l1484t1432r1610b1511],
7	warfarin	NN	O	warfarin	prep_for	5	SENT_6	[p1l1638t1432r2006b1511],
8	(	CD	NUMBER	(	num	11	SENT_6	[p1l675t1561r1188b1653],
9	Coumadin	NNP	O	Coumadin	nn	11	SENT_6	[p1l675t1561r1188b1653],
10	)	CD	NUMBER	)	num	11	SENT_6	[p1l675t1561r1188b1653],
11	NDA	NNP	ORGANIZATION	NDA	tmod	4	SENT_6	[p1l1228t1568r1443b1640],
12	9-218/5	CD	NUMBER	9-218/5	num	13	SENT_6	[p1l1478t1567r2003b1651],
13	-105	CD	NUMBER	-105	dep	11	SENT_6	[p1l1478t1567r2003b1651],

1	Pharmacogenomics	NNP	MISC	Pharmacogenomics	nsubj	3	SENT_7	[p1l6t1819r874b1920],
2	is	VBZ	O	be	aux	3	SENT_7	[p1l920t1820r987b1898],
3	receiving	VBG	O	receive	_	0	SENT_7	[p1l1033t1820r1434b1920],
4	a	DT	O	a	det	6	SENT_7	[p1l1474t1846r1519b1898],
5	great	JJ	O	great	amod	6	SENT_7	[p1l1562t1836r1788b1920],
6	deal	NN	O	deal	dobj	3	SENT_7	[p1l1828t1819r2008b1898],
7	of	IN	O	of	_	0	SENT_7	[p1l2052t1819r2153b1898],
8	attention	NN	O	attention	prep_of	6	SENT_7	[p1l7t1948r388b2026],
9	in	IN	O	in	_	0	SENT_7	[p1l424t1948r506b2025],
10	scientific	JJ	O	scientific	amod	11	SENT_7	[p1l544t1947r928b2026],
11	circles	NNS	O	circle	prep_in	3	SENT_7	[p1l965t1947r1228b2026],
12	and	CC	O	and	_	0	SENT_7	[p1l1266t1947r1444b2043],
13	,	,	O	,	_	0	SENT_7	[p1l1266t1947r1444b2043],
14	increasingly	RB	O	increasingly	dep	3	SENT_7	[p1l1485t1947r2011b2048],
15	,	,	O	,	_	0	SENT_7	[p1l1485t1947r2011b2048],
16	in	IN	O	in	_	0	SENT_7	[p1l2053t1948r2135b2025],
17	the	DT	O	the	det	19	SENT_7	[p1l8t2075r141b2154],
18	popular	JJ	O	popular	amod	19	SENT_7	[p1l175t2075r516b2176],
19	press	NN	O	press	conj_and	11	SENT_7	[p1l545t2101r768b2176],
20	because	IN	O	because	_	0	SENT_7	[p1l806t2075r1143b2154],
21	of	IN	O	of	_	0	SENT_7	[p1l1179t2075r1279b2154],
22	the	DT	O	the	det	23	SENT_7	[p1l1296t2075r1429b2154],
23	promise	NN	O	promise	prep_because_of	3	SENT_7	[p1l1462t2076r1814b2176],
24	of	IN	O	of	_	0	SENT_7	[p1l1851t2075r1951b2154],
25	personalized	JJ	O	personalized	amod	26	SENT_7	[p1l1966t2101r2134b2176, p1l9t2203r415b2282],
26	medicine	NN	O	medicine	prep_of	23	SENT_7	[p1l443t2203r852b2282],
27	.	.	O	.	_	0	SENT_7	[p1l443t2203r852b2282],

1	Short	NNP	O	Short	nsubj	18	SENT_8	[p1l889t2203r1116b2282],
2	of	IN	O	of	_	0	SENT_8	[p1l1141t2203r1240b2282],
3	being	VBG	O	be	cop	4	SENT_8	[p1l1252t2203r1490b2304],
4	able	JJ	O	able	prepc_of	1	SENT_8	[p1l1515t2203r1684b2282],
5	to	TO	O	to	aux	6	SENT_8	[p1l1713t2220r1795b2282],
6	cure	VB	O	cure	dep	4	SENT_8	[p1l1826t2229r2004b2282],
7	an	DT	O	a	det	8	SENT_8	[p1l2034t2229r2135b2282],
8	illness	NN	O	illness	dobj	6	SENT_8	[p1l7t2331r283b2410],
9	or	CC	O	or	_	0	SENT_8	[p1l323t2357r412b2410],
10	to	TO	O	to	aux	11	SENT_8	[p1l446t2348r527b2410],
11	prevent	VB	O	prevent	dep	4	SENT_8	[p1l563t2348r884b2432],
12	one	CD	NUMBER	one	dobj	11	SENT_8	[p1l916t2357r1091b2427],
13	,	,	O	,	_	0	SENT_8	[p1l916t2357r1091b2427],
14	every	DT	O	every	det	15	SENT_8	[p1l1134t2357r1355b2432],
15	clinician	NN	O	clinician	poss	17	SENT_8	[p1l1388t2331r1821b2410],
16	’s	POS	O	’s	_	0	SENT_8	[p1l1388t2331r1821b2410],
17	dream	NN	O	dream	appos	12	SENT_8	[p1l1859t2331r2135b2410],
18	is	VBZ	O	be	_	0	SENT_8	[p1l7t2460r72b2538],
19	to	TO	O	to	aux	20	SENT_8	[p1l113t2476r195b2538],
20	offer	VB	O	offer	xcomp	18	SENT_8	[p1l235t2459r442b2538],
21	patients	NNS	O	patient	iobj	20	SENT_8	[p1l475t2460r817b2560],
22	a	DT	O	a	det	25	SENT_8	[p1l857t2486r901b2538],
23	precisely	RB	O	precisely	advmod	24	SENT_8	[p1l936t2459r1315b2560],
24	targeted	VBN	O	target	amod	25	SENT_8	[p1l1348t2459r1704b2560],
25	drug	NN	O	drug	dobj	20	SENT_8	[p1l1743t2459r1947b2560],
26	at	IN	O	at	_	0	SENT_8	[p1l1981t2476r2060b2538],
27	a	DT	O	a	det	30	SENT_8	[p1l2092t2486r2136b2538],
28	precisely	RB	O	precisely	advmod	29	SENT_8	[p1l6t2587r376b2688],
29	calibrated	VBN	O	calibrate	amod	30	SENT_8	[p1l408t2587r826b2666],
30	dose	NN	O	dose	prep_at	25	SENT_8	[p1l862t2587r1054b2666],
31	to	TO	O	to	aux	32	SENT_8	[p1l1091t2604r1171b2666],
32	address	VB	O	address	dep	30	SENT_8	[p1l1207t2587r1526b2666],
33	a	DT	O	a	det	36	SENT_8	[p1l1563t2614r1608b2666],
34	specific	JJ	O	specific	amod	36	SENT_8	[p1l1644t2587r1967b2688],
35	ailment	NN	O	ailment	nn	36	SENT_8	[p1l2002t2587r2134b2666, p1l7t2732r232b2794],
36	—	NN	O	—	dobj	32	SENT_8	[p1l269t2760r377b2768],
37	and	CC	O	and	_	0	SENT_8	[p1l417t2715r578b2794],
38	to	TO	O	to	aux	39	SENT_8	[p1l624t2732r706b2794],
39	do	VB	O	do	dep	30	SENT_8	[p1l754t2715r858b2794],
40	so	RB	O	so	advmod	39	SENT_8	[p1l906t2741r998b2794],
41	without	IN	O	without	_	0	SENT_8	[p1l1041t2715r1387b2795],
42	wreaking	VBG	O	wreak	prepc_without	39	SENT_8	[p1l1423t2715r1844b2816],
43	havoc	NN	O	havoc	dobj	42	SENT_8	[p1l1886t2715r2136b2794],
44	on	IN	O	on	_	0	SENT_8	[p1l8t2869r115b2922],
45	the	DT	O	the	det	46	SENT_8	[p1l148t2843r282b2922],
46	rest	NN	O	rest	prep_on	42	SENT_8	[p1l316t2860r476b2922],
47	of	IN	O	of	_	0	SENT_8	[p1l505t2843r605b2922],
48	the	DT	O	the	det	49	SENT_8	[p1l621t2843r754b2922],
49	body	NN	O	body	prep_of	46	SENT_8	[p1l789t2843r1012b2944],
50	.	.	O	.	_	0	SENT_8	[p1l789t2843r1012b2944],

1	We	PRP	O	we	nsubj	2	SENT_9	[p1l1048t2851r1181b2922],
2	have	VBP	O	have	_	0	SENT_9	[p1l1215t2843r1405b2923],
3	ample	JJ	O	ample	amod	4	SENT_9	[p1l1439t2843r1699b2944],
4	reason	NN	O	reason	dobj	2	SENT_9	[p1l1733t2869r2019b2922],
5	to	TO	O	to	aux	6	SENT_9	[p1l2053t2860r2134b2922],
6	anticipate	VB	O	anticipate	infmod	4	SENT_9	[p1l7t2972r437b3072],
7	that	DT	O	that	det	8	SENT_9	[p1l491t2971r667b3050],
8	pharmacogenomics	NNS	O	pharmacogenomic	nsubj	10	SENT_9	[p1l714t2971r1584b3072],
9	will	MD	O	will	aux	10	SENT_9	[p1l1635t2971r1804b3051],
10	get	VB	O	get	ccomp	6	SENT_9	[p1l1856t2988r1992b3072],
11	us	PRP	O	we	dobj	10	SENT_9	[p1l2039t2998r2133b3050],
12	there	RB	O	there	advmod	10	SENT_9	[p1l8t3099r249b3195],
13	,	,	O	,	_	0	SENT_9	[p1l8t3099r249b3195],
14	but	CC	O	but	_	0	SENT_9	[p1l298t3099r438b3178],
15	it	PRP	O	it	nsubj	18	SENT_9	[p1l475t3100r534b3178],
16	is	VBZ	O	be	cop	18	SENT_9	[p1l571t3100r637b3178],
17	a	DT	O	a	det	18	SENT_9	[p1l681t3126r725b3178],
18	promise	NN	O	promise	conj_but	2	SENT_9	[p1l765t3100r1117b3200],
19	that	WDT	O	that	nsubj	20	SENT_9	[p1l1161t3099r1334b3178],
20	has	VBZ	O	have	rcmod	18	SENT_9	[p1l1371t3099r1516b3178],
21	yet	RB	O	yet	advmod	20	SENT_9	[p1l1556t3116r1681b3200],
22	to	TO	O	to	aux	24	SENT_9	[p1l1719t3116r1801b3178],
23	be	VB	O	be	auxpass	24	SENT_9	[p1l1845t3099r1942b3178],
24	fulﬁlled	VBN	O	fulﬁlled	xcomp	20	SENT_9	[p1l1985t3099r2134b3178, p1l7t3227r252b3306],
25	.	.	O	.	_	0	SENT_9	[p1l1985t3099r2134b3178, p1l7t3227r252b3306],

1	Therefore	RB	O	therefore	advmod	6	SENT_10	[p1l287t3227r720b3323],
2	,	,	O	,	_	0	SENT_10	[p1l287t3227r720b3323],
3	many	JJ	O	many	amod	4	SENT_10	[p1l759t3253r994b3328],
4	clinicians	NNS	O	clinician	nsubjpass	6	SENT_10	[p1l1024t3227r1428b3306],
5	are	VBP	O	be	auxpass	6	SENT_10	[p1l1462t3253r1589b3306],
6	left	VBN	O	leave	_	0	SENT_10	[p1l1623t3227r1763b3306],
7	wondering	VBG	O	wonder	xcomp	6	SENT_10	[p1l1787t3227r2134b3307, p1l7t3356r147b3456],
8	whether	IN	O	whether	complm	10	SENT_10	[p1l170t3355r527b3434],
9	pharmacogenomics	NNS	O	pharmacogenomic	nsubj	10	SENT_10	[p1l554t3355r1408b3456],
10	represents	VBZ	O	represent	ccomp	7	SENT_10	[p1l1442t3372r1885b3456],
11	great	JJ	O	great	amod	12	SENT_10	[p1l1919t3372r2140b3456],
12	hope	NN	O	hope	dobj	10	SENT_10	[p1l7t3483r235b3584],
13	,	,	O	,	_	0	SENT_10	[p1l7t3483r235b3584],
14	overblown	JJ	O	overblown	amod	15	SENT_10	[p1l277t3483r716b3562],
15	hype	NN	O	hype	conj_or	12	SENT_10	[p1l752t3483r974b3584],
16	,	,	O	,	_	0	SENT_10	[p1l752t3483r974b3584],
17	or	CC	O	or	_	0	SENT_10	[p1l1016t3509r1103b3562],
18	something	NN	O	something	dobj	10	SENT_10	[p1l1138t3483r1594b3584],
19	in	IN	O	in	prep	18	SENT_10	[p1l1626t3484r1708b3561],
20	between	IN	O	between	pobj	19	SENT_10	[p1l1745t3483r2119b3563],
21	.	.	O	.	_	0	SENT_10	[p1l1745t3483r2119b3563],

1	Although	IN	O	although	mark	24	SENT_11	[p1l133t3611r534b3712],
2	the	DT	O	the	det	4	SENT_11	[p1l572t3611r703b3690],
3	term	NN	O	term	nn	4	SENT_11	[p1l741t3628r940b3690],
4	pharmacogenomics	NNS	O	pharmacogenomic	nsubjpass	24	SENT_11	[p1l976t3611r1838b3712],
5	,	,	O	,	_	0	SENT_11	[p1l976t3611r1838b3712],
6	which	WDT	O	which	nsubj	7	SENT_11	[p1l1876t3611r2135b3690],
7	describes	VBZ	O	describe	rcmod	4	SENT_11	[p2l8t20r407b99],
8	a	DT	O	a	det	9	SENT_11	[p2l454t47r499b99],
9	field	NN	O	field	dobj	7	SENT_11	[p2l543t20r737b99],
10	of	IN	O	of	_	0	SENT_11	[p2l783t20r883b99],
11	study	NN	O	study	prep_of	9	SENT_11	[p2l912t20r1143b121],
12	in	IN	O	in	_	0	SENT_11	[p2l1183t21r1267b98],
13	which	WDT	O	which	rel	15	SENT_11	[p2l1308t20r1571b100],
14	genetics	NNS	O	genetics	nsubj	15	SENT_11	[p2l1617t21r1968b121],
15	explains	VBZ	O	explain	rcmod	9	SENT_11	[p2l2017t47r2134b99, p2l6t148r268b249],
16	individual	JJ	O	individual	amod	17	SENT_11	[p2l312t148r745b227],
17	differences	NNS	O	difference	dobj	15	SENT_11	[p2l788t148r1265b227],
18	in	IN	O	in	_	0	SENT_11	[p2l1309t149r1393b226],
19	drug	NN	O	drug	nn	20	SENT_11	[p2l1436t148r1641b249],
20	responses	NNS	O	response	prep_in	17	SENT_11	[p2l1681t174r2130b249],
21	,	,	O	,	_	0	SENT_11	[p2l1681t174r2130b249],
22	has	VBZ	O	have	aux	24	SENT_11	[p2l7t276r152b355],
23	been	VBN	O	be	auxpass	24	SENT_11	[p2l188t276r390b355],
24	used	VBN	O	use	advcl	39	SENT_11	[p2l424t276r622b355],
25	for	IN	O	for	_	0	SENT_11	[p2l655t276r779b355],
26	decades	NNS	DURATION	decade	prep_for	24	SENT_11	[p2l810t276r1146b355],
27	by	IN	O	by	_	0	SENT_11	[p2l1182t276r1279b377],
28	research	NN	O	research	nn	29	SENT_11	[p2l1309t276r1672b355],
29	scientists	NNS	O	scientist	agent	24	SENT_11	[p2l1707t277r2130b372],
30	,	,	O	,	_	0	SENT_11	[p2l1707t277r2130b372],
31	only	RB	O	only	advmod	32	SENT_11	[p2l8t404r190b505],
32	recently	RB	DATE	recently	advmod	39	SENT_11	[p2l223t404r556b505],
33	have	VB	O	have	aux	39	SENT_11	[p2l590t404r777b483],
34	health	NN	O	health	nn	36	SENT_11	[p2l815t404r1081b483],
35	care	NN	O	care	nn	36	SENT_11	[p2l1119t430r1292b483],
36	providers	NNS	O	provider	dobj	39	SENT_11	[p2l1328t404r1720b505],
37	and	CC	O	and	_	0	SENT_11	[p2l1759t404r1915b483],
38	consumers	NNS	O	consumer	dobj	39	SENT_11	[p2l1954t430r2134b483, p2l9t558r312b611],
39	begun	VBN	O	begin	_	0	SENT_11	[p2l351t532r617b633],
40	to	TO	O	to	aux	41	SENT_11	[p2l654t549r734b611],
41	stand	VB	O	stand	xcomp	39	SENT_11	[p2l774t532r1005b611],
42	up	RP	O	up	prt	41	SENT_11	[p2l1042t558r1144b633],
43	and	CC	O	and	_	0	SENT_11	[p2l1182t532r1337b611],
44	take	VB	O	take	conj_and	39	SENT_11	[p2l1374t532r1551b612],
45	notice	NN	O	notice	dobj	44	SENT_11	[p2l1588t533r1866b611],
46	.	.	O	.	_	0	SENT_11	[p2l1588t533r1866b611],

1	Technological	JJ	O	technological	amod	2	SENT_12	[p2l1905t532r2134b611, p2l7t660r406b761],
2	advances	NNS	O	advance	nsubj	27	SENT_12	[p2l439t660r822b739],
3	that	WDT	O	that	nsubj	4	SENT_12	[p2l859t660r1033b739],
4	make	VBP	O	make	rcmod	2	SENT_12	[p2l1062t660r1295b740],
5	it	PRP	O	it	nsubj	6	SENT_12	[p2l1329t661r1389b739],
6	possible	JJ	O	possible	xcomp	4	SENT_12	[p2l1417t660r1768b761],
7	to	TO	O	to	aux	8	SENT_12	[p2l1804t677r1885b739],
8	identify	VB	O	identify	dep	6	SENT_12	[p2l1920t660r2134b739, p2l8t788r155b889],
9	millions	NNS	O	million	dobj	8	SENT_12	[p2l189t788r547b867],
10	of	IN	O	of	_	0	SENT_12	[p2l588t788r688b867],
11	DNA	NN	O	dna	nn	13	SENT_12	[p2l707t795r915b867],
12	sequence	NN	O	sequence	nn	13	SENT_12	[p2l953t814r1342b889],
13	variations	NNS	O	variation	prep_of	9	SENT_12	[p2l1376t789r1802b867],
14	rapidly	RB	O	rapidly	advmod	8	SENT_12	[p2l1842t788r2140b889],
15	and	CC	O	and	_	0	SENT_12	[p2l7t916r167b995],
16	inexpensively	RB	O	inexpensively	conj_and	14	SENT_12	[p2l218t916r823b1017],
17	,	,	O	,	_	0	SENT_12	[p2l218t916r823b1017],
18	and	CC	O	and	_	0	SENT_12	[p2l880t916r1040b995],
19	to	TO	O	to	aux	20	SENT_12	[p2l1092t933r1174b995],
20	correlate	VB	O	correlate	dep	6	SENT_12	[p2l1228t916r1612b995],
21	them	PRP	O	they	dobj	20	SENT_12	[p2l1665t916r1889b995],
22	with	IN	O	with	_	0	SENT_12	[p2l1936t916r2135b995],
23	phenotypic	JJ	O	phenotypic	amod	24	SENT_12	[p2l6t1044r487b1145],
24	characteristics	NNS	O	characteristic	prep_with	20	SENT_12	[p2l522t1044r1170b1140],
25	,	,	O	,	_	0	SENT_12	[p2l522t1044r1170b1140],
26	have	VBP	O	have	aux	27	SENT_12	[p2l1210t1044r1400b1123],
27	fueled	VBN	O	fuel	_	0	SENT_12	[p2l1435t1044r1699b1123],
28	an	DT	O	a	det	29	SENT_12	[p2l1732t1070r1836b1123],
29	explosion	NN	O	explosion	dobj	27	SENT_12	[p2l1871t1044r2134b1145, p2l9t1173r188b1251],
30	of	IN	O	of	_	0	SENT_12	[p2l235t1172r336b1251],
31	knowledge	NN	O	knowledge	prep_of	29	SENT_12	[p2l364t1172r840b1273],
32	in	IN	O	in	_	0	SENT_12	[p2l886t1173r971b1250],
33	this	DT	O	this	det	35	SENT_12	[p2l1017t1172r1180b1251],
34	exciting	JJ	O	exciting	amod	35	SENT_12	[p2l1229t1173r1579b1273],
35	area	NN	O	area	prep_in	27	SENT_12	[p2l1621t1177r1929b1251],
36	.1	CD	NUMBER	.1	npadvmod	37	SENT_12	[p2l1621t1177r1929b1251],
37	>	JJR	O	>	conj_and	37	SENT_12	[p2l1621t1177r1929b1251],
38	2	CD	NUMBER	2	dep	37	SENT_12	[p2l1621t1177r1929b1251],
39	The	DT	O	the	det	43	SENT_12	[p2l1972t1172r2135b1251],
40	long	JJ	O	long	amod	43	SENT_12	[p2l6t1300r443b1401],
41	—	NN	O	—	nn	43	SENT_12	[p2l6t1300r443b1401],
42	term	NN	O	term	nn	43	SENT_12	[p2l6t1300r443b1401],
43	vision	NN	O	vision	npadvmod	37	SENT_12	[p2l482t1301r743b1379],
44	of	IN	O	of	_	0	SENT_12	[p2l787t1300r888b1379],
45	uncovering	VBG	O	uncover	amod	47	SENT_12	[p2l912t1301r1406b1401],
46	new	JJ	O	new	amod	47	SENT_12	[p2l1445t1326r1625b1380],
47	targets	NNS	O	target	prep_of	43	SENT_12	[p2l1665t1317r1967b1401],
48	for	IN	O	for	_	0	SENT_12	[p2l2012t1300r2138b1379],
49	pharmacologic	JJ	O	pharmacologic	amod	50	SENT_12	[p2l6t1428r667b1529],
50	intervention	NN	O	intervention	prep_for	37	SENT_12	[p2l713t1429r1252b1507],
51	and	CC	O	and	_	0	SENT_12	[p2l1298t1428r1483b1524],
52	,	,	O	,	_	0	SENT_12	[p2l1298t1428r1483b1524],
53	ultimately	RB	O	ultimately	advmod	37	SENT_12	[p2l1536t1428r1999b1529],
54	,	,	O	,	_	0	SENT_12	[p2l1536t1428r1999b1529],
55	of	IN	O	of	_	0	SENT_12	[p2l2052t1428r2153b1507],
56	creating	VBG	O	create	prepc_of	37	SENT_12	[p2l8t1557r354b1657],
57	a	DT	O	a	det	59	SENT_12	[p2l384t1583r429b1635],
58	broad	JJ	O	broad	amod	59	SENT_12	[p2l461t1556r702b1635],
59	selection	NN	O	selection	nsubj	63	SENT_12	[p2l737t1556r1108b1635],
60	of	IN	O	of	_	0	SENT_12	[p2l1143t1556r1241b1635],
61	custom	NN	O	custom	prep_of	59	SENT_12	[p2l1258t1556r1829b1635],
62	—	CD	NUMBER	—	num	61	SENT_12	[p2l1258t1556r1829b1635],
63	made	VBD	O	make	ccomp	56	SENT_12	[p2l1258t1556r1829b1635],
64	agents	NNS	O	agent	dobj	63	SENT_12	[p2l1862t1573r2134b1657],
65	for	IN	O	for	_	0	SENT_12	[p2l7t1684r128b1763],
66	individualized	JJ	O	individualized	amod	68	SENT_12	[p2l151t1684r749b1763],
67	treatment	NN	O	treatment	nn	68	SENT_12	[p2l775t1701r1188b1763],
68	glimmers	NNS	O	glimmer	prep_for	63	SENT_12	[p2l1210t1684r1615b1785],
69	tantalizingly	RB	O	tantalizingly	advmod	63	SENT_12	[p2l1644t1684r2134b1785, p2l6t1812r93b1913],
70	,	,	O	,	_	0	SENT_12	[p2l1644t1684r2134b1785, p2l6t1812r93b1913],
71	if	IN	O	if	mark	72	SENT_12	[p2l144t1812r222b1890],
72	distantly	RB	O	distantly	parataxis	63	SENT_12	[p2l251t1812r652b1913],
73	,	,	O	,	_	0	SENT_12	[p2l251t1812r652b1913],
74	on	IN	O	on	_	0	SENT_12	[p2l704t1838r812b1891],
75	the	DT	O	the	det	76	SENT_12	[p2l858t1812r994b1891],
76	horizon	NN	O	horizon	prep_on	63	SENT_12	[p2l1040t1812r1408b1891],
77	.	.	O	.	_	0	SENT_12	[p2l1040t1812r1408b1891],

1	Much	RB	O	much	nsubj	10	SENT_13	[p2l1457t1812r1702b1891],
2	closer	JJR	O	closer	amod	1	SENT_13	[p2l1748t1812r2008b1891],
3	to	TO	O	to	prep	2	SENT_13	[p2l2052t1829r2134b1891],
4	near	IN	O	near	_	0	SENT_13	[p2l7t1957r434b2019],
5	—	NN	O	—	nn	7	SENT_13	[p2l7t1957r434b2019],
6	term	NN	O	term	nn	7	SENT_13	[p2l7t1957r434b2019],
7	application	NN	O	application	prep_near	2	SENT_13	[p2l478t1940r959b2041],
8	is	VBZ	O	be	cop	10	SENT_13	[p2l1004t1941r1070b2019],
9	the	DT	O	the	det	10	SENT_13	[p2l1118t1940r1250b2019],
10	use	NN	O	use	_	0	SENT_13	[p2l1297t1967r1437b2019],
11	of	IN	O	of	_	0	SENT_13	[p2l1484t1940r1584b2019],
12	information	NN	O	information	prep_of	10	SENT_13	[p2l1610t1940r2135b2019],
13	about	IN	O	about	_	0	SENT_13	[p2l7t2068r256b2147],
14	how	WRB	O	how	advmod	17	SENT_13	[p2l289t2068r476b2147],
15	genetic	JJ	O	genetic	amod	16	SENT_13	[p2l510t2069r826b2169],
16	variations	NNS	O	variation	nsubj	17	SENT_13	[p2l859t2069r1295b2147],
17	affect	VBP	O	affect	prepc_about	12	SENT_13	[p2l1334t2068r1587b2147],
18	the	DT	O	the	det	19	SENT_13	[p2l1620t2068r1756b2147],
19	efficacy	NN	O	efficacy	nsubj	23	SENT_13	[p2l1795t2068r2140b2169],
20	of	IN	O	of	_	0	SENT_13	[p2l12t2196r113b2275],
21	drugs	NNS	O	drug	prep_of	19	SENT_13	[p2l131t2196r370b2297],
22	to	TO	O	to	aux	23	SENT_13	[p2l404t2213r484b2275],
23	guide	VB	O	guide	xcomp	17	SENT_13	[p2l517t2196r751b2297],
24	prescribing	VBG	O	prescribe	amod	25	SENT_13	[p2l781t2196r1263b2297],
25	decisions	NNS	O	decision	dobj	23	SENT_13	[p2l1292t2196r1678b2275],
26	for	IN	O	for	_	0	SENT_13	[p2l1711t2196r1832b2275],
27	agents	NNS	O	agent	prep_for	23	SENT_13	[p2l1860t2213r2130b2297],
28	currently	RB	DATE	currently	advmod	23	SENT_13	[p2l12t2324r402b2425],
29	on	IN	O	on	_	0	SENT_13	[p2l441t2350r547b2403],
30	the	DT	O	the	det	31	SENT_13	[p2l591t2324r723b2403],
31	market	NN	O	market	prep_on	23	SENT_13	[p2l767t2324r1094b2404],
32	.	.	O	.	_	0	SENT_13	[p2l767t2324r1094b2404],

1	Indeed	RB	O	indeed	advmod	6	SENT_14	[p2l1142t2324r1458b2420],
2	,	,	O	,	_	0	SENT_14	[p2l1142t2324r1458b2420],
3	it	PRP	O	it	nsubj	6	SENT_14	[p2l1506t2325r1565b2403],
4	is	VBZ	O	be	cop	6	SENT_14	[p2l1603t2325r1669b2403],
5	not	RB	O	not	neg	6	SENT_14	[p2l1714t2341r1857b2403],
6	much	JJ	O	much	_	0	SENT_14	[p2l1895t2324r2133b2403],
7	of	IN	O	of	_	0	SENT_14	[p2l12t2452r112b2531],
8	a	DT	O	a	det	9	SENT_14	[p2l132t2479r177b2531],
9	stretch	NN	O	stretch	prep_of	6	SENT_14	[p2l217t2452r509b2531],
10	to	TO	O	to	aux	11	SENT_14	[p2l550t2469r631b2531],
11	imagine	VB	O	imagine	infmod	9	SENT_14	[p2l671t2453r1022b2553],
12	that	DT	O	that	dobj	11	SENT_14	[p2l1063t2452r1235b2531],
13	someday	RB	O	someday	advmod	11	SENT_14	[p2l1272t2452r1649b2553],
14	soon	RB	O	soon	advmod	21	SENT_14	[p2l1685t2478r1889b2531],
15	DNA	NN	O	dna	nn	16	SENT_14	[p2l1928t2459r2137b2531],
16	sequencing	NN	O	sequencing	nsubj	21	SENT_14	[p2l13t2581r499b2681],
17	will	MD	O	will	aux	21	SENT_14	[p2l531t2580r695b2660],
18	be	VB	O	be	cop	21	SENT_14	[p2l734t2580r830b2659],
19	a	DT	O	a	det	21	SENT_14	[p2l870t2607r914b2659],
20	routine	JJ	O	routine	amod	21	SENT_14	[p2l952t2581r1261b2659],
21	part	NN	O	part	dep	11	SENT_14	[p2l1299t2597r1479b2681],
22	of	IN	O	of	_	0	SENT_14	[p2l1514t2580r1613b2659],
23	the	DT	O	the	det	24	SENT_14	[p2l1635t2580r1768b2659],
24	workup	NN	O	workup	prep_of	21	SENT_14	[p2l1802t2580r2132b2681],
25	for	IN	O	for	_	0	SENT_14	[p2l11t2708r132b2787],
26	patients	NNS	O	patient	prep_for	24	SENT_14	[p2l159t2709r517b2809],
27	,	,	O	,	_	0	SENT_14	[p2l159t2709r517b2809],
28	at	IN	O	at	_	0	SENT_14	[p2l554t2725r631b2787],
29	the	DT	O	the	det	31	SENT_14	[p2l658t2708r789b2787],
30	very	RB	O	very	advmod	31	SENT_14	[p2l816t2735r990b2809],
31	least	JJS	O	least	prep_at	6	SENT_14	[p2l1017t2708r1212b2787],
32	to	TO	O	to	aux	33	SENT_14	[p2l1239t2725r1319b2787],
33	identify	VB	O	identify	xcomp	6	SENT_14	[p2l1351t2708r1676b2809],
34	a	DT	O	a	det	35	SENT_14	[p2l1703t2735r1747b2787],
35	patient	NN	O	patient	poss	37	SENT_14	[p2l1776t2709r2130b2809],
36	’s	POS	O	’s	_	0	SENT_14	[p2l1776t2709r2130b2809],
37	sensitivity	NN	O	sensitivity	dobj	33	SENT_14	[p2l13t2837r446b2937],
38	to	TO	O	to	_	0	SENT_14	[p2l477t2853r558b2915],
39	drugs	NNS	O	drug	prep_to	33	SENT_14	[p2l596t2836r839b2937],
40	that	WDT	O	that	nsubj	42	SENT_14	[p2l877t2836r1049b2915],
41	are	VBP	O	be	cop	42	SENT_14	[p2l1079t2863r1208b2915],
42	likely	JJ	O	likely	rcmod	39	SENT_14	[p2l1242t2836r1475b2937],
43	to	TO	O	to	aux	44	SENT_14	[p2l1506t2853r1587b2915],
44	produce	VB	O	produce	xcomp	42	SENT_14	[p2l1622t2836r1968b2937],
45	adverse	JJ	O	adverse	amod	46	SENT_14	[p2l2002t2836r2132b2915, p2l7t2991r223b3044],
46	effects	NNS	O	effect	dobj	44	SENT_14	[p2l261t2965r567b3044],
47	.	.	O	.	_	0	SENT_14	[p2l261t2965r567b3044],

1	Achieving	VBG	O	achieve	csubj	14	SENT_15	[p2l136t3093r561b3194],
2	effective	JJ	O	effective	amod	5	SENT_15	[p2l596t3093r946b3172],
3	and	CC	O	and	_	0	SENT_15	[p2l983t3093r1139b3172],
4	safe	JJ	O	safe	conj_and	2	SENT_15	[p2l1179t3093r1342b3172],
5	administration	NN	O	administration	dobj	1	SENT_15	[p2l1381t3093r2013b3172],
6	of	IN	O	of	_	0	SENT_15	[p2l2052t3093r2151b3172],
7	warfarin	NN	O	warfarin	nn	8	SENT_15	[p2l7t3221r381b3301],
8	therapy	NN	O	therapy	prep_of	5	SENT_15	[p2l427t3221r750b3322],
9	has	VBZ	O	have	aux	14	SENT_15	[p2l791t3221r935b3300],
10	been	VBN	O	be	cop	14	SENT_15	[p2l983t3221r1185b3300],
11	both	CC	O	both	preconj	14	SENT_15	[p2l1231t3221r1429b3300],
12	an	DT	O	a	det	14	SENT_15	[p2l1475t3247r1577b3300],
13	urgent	JJ	O	urgent	amod	14	SENT_15	[p2l1623t3238r1907b3322],
14	concern	NN	O	concern	_	0	SENT_15	[p2l1948t3247r2132b3300, p2l12t3375r196b3428],
15	for	IN	O	for	_	0	SENT_15	[p2l236t3349r359b3428],
16	clinicians	NNS	O	clinician	prep_for	14	SENT_15	[p2l398t3349r809b3428],
17	and	CC	O	and	_	0	SENT_15	[p2l852t3349r1009b3428],
18	an	DT	O	a	det	20	SENT_15	[p2l1049t3375r1152b3428],
19	outstanding	JJ	O	outstanding	amod	20	SENT_15	[p2l1194t3349r1718b3450],
20	opportunity	NN	O	opportunity	conj_and	14	SENT_15	[p2l1756t3366r2132b3450, p2l11t3478r181b3578],
21	for	IN	O	for	_	0	SENT_15	[p2l221t3477r347b3556],
22	researchers	NNS	O	researcher	prep_for	20	SENT_15	[p2l389t3477r888b3556],
23	to	TO	O	to	aux	24	SENT_15	[p2l936t3494r1018b3556],
24	explore	VB	O	explore	infmod	22	SENT_15	[p2l1066t3477r1383b3578],
25	the	DT	O	the	det	26	SENT_15	[p2l1429t3477r1564b3556],
26	potential	NN	O	potential	dobj	24	SENT_15	[p2l1608t3477r2005b3578],
27	of	IN	O	of	_	0	SENT_15	[p2l2050t3477r2151b3556],
28	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	26	SENT_15	[p2l10t3605r887b3706],
29	.	.	O	.	_	0	SENT_15	[p2l10t3605r887b3706],

1	The	DT	O	the	det	2	SENT_16	[p2l930t3605r1092b3684],
2	administration	NN	O	administration	_	0	SENT_16	[p2l1133t3605r1779b3684],
3	of	IN	O	of	_	0	SENT_16	[p2l1822t3605r1922b3684],
4	warfarm	NN	O	warfarm	prep_of	2	SENT_16	[p2l1941t3632r2132b3684, p3l11t20r214b99],

1	is	VBZ	O	be	cop	2	SENT_17	[p3l251t21r315b99],
2	tricky	JJ	O	tricky	_	0	SENT_17	[p3l356t20r599b121],
3	because	IN	O	because	_	0	SENT_17	[p3l634t20r964b99],
4	of	IN	O	of	prepc_because_of	2	SENT_17	[p3l1003t20r1101b99],
5	the	DT	O	the	det	6	SENT_17	[p3l1121t20r1252b99],
6	drug	NN	O	drug	poss	12	SENT_17	[p3l1290t20r1551b121],
7	’s	POS	O	’s	_	0	SENT_17	[p3l1290t20r1551b121],
8	narrow	JJ	O	narrow	amod	12	SENT_17	[p3l1592t46r1900b99],
9	ther	NN	O	ther	nn	12	SENT_17	[p3l1934t20r2132b99],
10	—	NN	O	—	nn	12	SENT_17	[p3l1934t20r2132b99],
11	apeutic	JJ	O	apeutic	amod	12	SENT_17	[p3l11t149r313b249],
12	range	NN	O	range	pobj	2	SENT_17	[p3l349t174r585b249],
13	and	CC	O	and	_	0	SENT_17	[p3l621t148r776b227],
14	the	DT	O	the	det	16	SENT_17	[p3l813t148r944b227],
15	large	JJ	O	large	amod	16	SENT_17	[p3l979t148r1189b249],
16	variations	NNS	O	variation	conj_and	12	SENT_17	[p3l1221t149r1636b228],
17	in	IN	O	in	_	0	SENT_17	[p3l1674t149r1756b226],
18	dose	NN	O	dose	nn	21	SENT_17	[p3l1793t148r1984b227],
19	re	NN	O	re	nn	21	SENT_17	[p3l2021t174r2132b227],
20	—	NN	O	—	nn	21	SENT_17	[p3l2021t174r2132b227],
21	quirements	NNS	O	quirement	prep_in	16	SENT_17	[p3l12t277r507b377],
22	from	IN	O	from	_	0	SENT_17	[p3l567t276r780b355],
23	one	CD	NUMBER	one	num	24	SENT_17	[p3l838t302r991b355],
24	patient	NN	O	patient	prep_from	2	SENT_17	[p3l1048t277r1356b377],
25	to	TO	O	to	_	0	SENT_17	[p3l1409t293r1491b355],
26	another	DT	O	another	prep_to	24	SENT_17	[p3l1549t276r1911b355],
27	.	.	O	.	_	0	SENT_17	[p3l1549t276r1911b355],

1	The	DT	O	the	det	2	SENT_18	[p3l1970t276r2133b355],
2	drug	NN	O	drug	nsubj	6	SENT_18	[p3l12t404r219b505],
3	is	VBZ	O	be	cop	6	SENT_18	[p3l261t405r326b483],
4	also	RB	O	also	advmod	6	SENT_18	[p3l372t404r544b483],
5	relatively	RB	O	relatively	advmod	6	SENT_18	[p3l590t404r976b505],
6	easy	JJ	O	easy	_	0	SENT_18	[p3l1016t431r1199b505],
7	to	TO	O	to	aux	8	SENT_18	[p3l1240t421r1321b483],
8	study	VB	O	study	xcomp	6	SENT_18	[p3l1369t404r1598b505],
9	because	IN	O	because	mark	11	SENT_18	[p3l1639t404r1975b483],
10	we	PRP	O	we	nsubj	11	SENT_18	[p3l2015t431r2133b483],
11	have	VBP	O	have	advcl	8	SENT_18	[p3l11t532r201b611],
12	what	WP	O	what	dep	14	SENT_18	[p3l236t532r451b611],
13	we	PRP	O	we	nsubj	14	SENT_18	[p3l480t559r598b611],
14	think	VBP	O	think	dep	25	SENT_18	[p3l638t532r875b612],
15	is	VBZ	O	be	cop	18	SENT_18	[p3l909t533r975b611],
16	a	DT	O	a	det	18	SENT_18	[p3l1015t559r1060b611],
17	good	JJ	O	good	amod	18	SENT_18	[p3l1097t532r1313b633],
18	measure	NN	O	measure	ccomp	14	SENT_18	[p3l1352t558r1737b628],
19	,	,	O	,	_	0	SENT_18	[p3l1352t558r1737b628],
20	the	DT	O	the	det	23	SENT_18	[p3l1783t532r1915b611],
21	prothrombin	NN	O	prothrombin	nn	23	SENT_18	[p3l1953t558r2132b633, p3l12t661r664b740],
22	—	NN	O	—	nn	23	SENT_18	[p3l1953t558r2132b633, p3l12t661r664b740],
23	time	NN	O	time	nsubj	25	SENT_18	[p3l1953t558r2132b633, p3l12t661r664b740],
24	international	JJ	O	international	amod	23	SENT_18	[p3l725t661r1301b740],
25	normalized	VBD	O	normalize	ccomp	11	SENT_18	[p3l1362t661r1869b740],
26	ratio	NN	O	ratio	dobj	25	SENT_18	[p3l1930t662r2132b740],

1	(	RB	O	(	advmod	7	SENT_19	[p3l16t796r158b881],
2	IN	IN	O	in	_	0	SENT_19	[p3l16t796r158b881],
3	R	NN	O	r	nn	4	SENT_19	[p3l163t796r284b885],
4	)	NN	O	)	prep_in	7	SENT_19	[p3l163t796r284b885],
5	,	,	O	,	_	0	SENT_19	[p3l163t796r284b885],
6	to	TO	O	to	nsubj	7	SENT_19	[p3l331t806r412b868],
7	track	VB	O	track	_	0	SENT_19	[p3l452t789r671b869],
8	a	DT	O	a	det	9	SENT_19	[p3l705t816r750b868],
9	patient	NN	O	patient	poss	11	SENT_19	[p3l786t790r1149b890],
10	’s	POS	O	’s	_	0	SENT_19	[p3l786t790r1149b890],
11	response	NN	O	response	dobj	7	SENT_19	[p3l1190t815r1570b890],
12	to	TO	O	to	_	0	SENT_19	[p3l1610t806r1692b868],
13	the	DT	O	the	det	14	SENT_19	[p3l1732t789r1865b868],
14	drug	NN	O	drug	prep_to	7	SENT_19	[p3l1905t789r2128b890],
15	.	.	O	.	_	0	SENT_19	[p3l1905t789r2128b890],

1	Research	NNP	O	Research	dep	168	SENT_20	[p3l9t917r394b1001],
2	has	VBZ	O	have	dep	168	SENT_20	[p3l423t917r565b996],
3	focused	VBN	O	focus	dep	168	SENT_20	[p3l597t917r923b996],
4	on	IN	O	on	dep	168	SENT_20	[p3l954t943r1058b996],
5	polymorphisms	NNS	O	polymorphism	dep	168	SENT_20	[p3l1086t917r1751b1018],
6	of	IN	O	of	dep	168	SENT_20	[p3l1784t917r1883b996],
7	genes	NNS	O	gene	dep	168	SENT_20	[p3l1894t943r2131b1018],
8	encoding	VBG	O	encode	dep	168	SENT_20	[p3l12t1045r402b1146],
9	two	CD	NUMBER	two	dep	168	SENT_20	[p3l431t1062r585b1124],
10	proteins	NNS	O	protein	dep	168	SENT_20	[p3l618t1046r984b1146],
11	:	:	O	:	_	0	SENT_20	[p3l618t1046r984b1146],
12	the	DT	O	the	dep	168	SENT_20	[p3l1021t1045r1151b1124],
13	cytochrome	NN	O	cytochrome	dep	168	SENT_20	[p3l1184t1045r1677b1146],
14	P	NN	O	p	dep	168	SENT_20	[p3l1708t1051r1940b1124],
15	—	CD	NUMBER	—	dep	168	SENT_20	[p3l1708t1051r1940b1124],
16	45O	NN	O	45o	dep	168	SENT_20	[p3l1708t1051r1940b1124],
17	2C9	NN	O	2c9	dep	168	SENT_20	[p3l1973t1051r2133b1124],
18	enzyme	NN	O	enzyme	dep	168	SENT_20	[p3l12t1199r336b1274],
19	(	CD	NUMBER	(	dep	168	SENT_20	[p3l379t1179r785b1269],
20	CYPZC9	NN	O	cypzc9	dep	168	SENT_20	[p3l379t1179r785b1269],
21	)	NN	O	)	dep	168	SENT_20	[p3l379t1179r785b1269],
22	,	,	O	,	_	0	SENT_20	[p3l379t1179r785b1269],
23	which	WDT	O	which	dep	168	SENT_20	[p3l823t1173r1082b1252],
24	is	VBZ	O	be	dep	168	SENT_20	[p3l1119t1174r1184b1252],
25	involved	VBN	O	involve	dep	168	SENT_20	[p3l1223t1173r1567b1253],
26	in	IN	O	in	dep	168	SENT_20	[p3l1604t1174r1686b1251],
27	the	DT	O	the	dep	168	SENT_20	[p3l1725t1173r1855b1252],
28	metabolic	JJ	O	metabolic	dep	168	SENT_20	[p3l1893t1190r2132b1252, p3l12t1300r224b1378],
29	clearance	NN	O	clearance	dep	168	SENT_20	[p3l269t1300r679b1378],
30	of	IN	O	of	dep	168	SENT_20	[p3l725t1300r826b1378],
31	warfarin	NN	O	warfarin	dep	168	SENT_20	[p3l848t1300r1254b1395],
32	,	,	O	,	_	0	SENT_20	[p3l848t1300r1254b1395],
33	and	CC	O	and	dep	168	SENT_20	[p3l1304t1300r1464b1378],
34	the	DT	O	the	dep	168	SENT_20	[p3l1509t1300r1644b1378],
35	vitamin	NN	O	vitamin	dep	168	SENT_20	[p3l1685t1301r2026b1379],
36	K	NN	O	k	dep	168	SENT_20	[p3l2070t1308r2137b1380],
37	epoxide	NN	O	epoxide	dep	168	SENT_20	[p3l12t1428r344b1529],
38	reductase	NN	O	reductase	dep	168	SENT_20	[p3l387t1428r795b1507],
39	enzyme	NN	O	enzyme	dep	168	SENT_20	[p3l839t1454r1169b1529],
40	(	CD	NUMBER	(	dep	168	SENT_20	[p3l1217t1434r1669b1524],
41	VKORC1	NN	O	vkorc1	dep	168	SENT_20	[p3l1217t1434r1669b1524],
42	)	NN	O	)	dep	168	SENT_20	[p3l1217t1434r1669b1524],
43	,	,	O	,	_	0	SENT_20	[p3l1217t1434r1669b1524],
44	which	WDT	O	which	dep	168	SENT_20	[p3l1713t1428r1976b1507],
45	re	VBP	O	re	dep	168	SENT_20	[p3l2019t1454r2132b1507],
46	—	NN	O	—	dep	168	SENT_20	[p3l2019t1454r2132b1507],
47	cycles	NNS	O	cycle	dep	168	SENT_20	[p3l12t1556r257b1657],
48	reduced	VBD	O	reduce	dep	168	SENT_20	[p3l296t1556r633b1635],
49	vitamin	NN	O	vitamin	dep	168	SENT_20	[p3l664t1557r999b1635],
50	K	NN	O	k	dep	168	SENT_20	[p3l1034t1564r1101b1637],
51	and	CC	O	and	dep	168	SENT_20	[p3l1133t1556r1291b1635],
52	is	VBZ	O	be	dep	168	SENT_20	[p3l1326t1557r1392b1635],
53	essential	JJ	O	essential	dep	168	SENT_20	[p3l1431t1556r1807b1635],
54	for	IN	O	for	dep	168	SENT_20	[p3l1842t1556r1966b1635],
55	the	DT	O	the	dep	168	SENT_20	[p3l2000t1556r2133b1635],
56	post	NN	O	post	dep	168	SENT_20	[p3l10t1684r778b1785],
57	—	CD	NUMBER	—	dep	168	SENT_20	[p3l10t1684r778b1785],
58	translational	JJ	O	translational	dep	168	SENT_20	[p3l10t1684r778b1785],
59	gamma	NN	O	gamma	dep	168	SENT_20	[p3l824t1684r1774b1785],
60	—	NN	O	—	dep	168	SENT_20	[p3l824t1684r1774b1785],
61	carboXylation	NN	O	carboxylation	dep	168	SENT_20	[p3l824t1684r1774b1785],
62	of	IN	O	of	dep	168	SENT_20	[p3l1822t1684r1921b1763],
63	vitamin	NN	O	vitamin	dep	168	SENT_20	[p3l1946t1685r2132b1764, p3l11t1813r185b1890],
64	K	NN	O	k	dep	168	SENT_20	[p3l220t1812r800b1913],
65	—	NN	O	—	dep	168	SENT_20	[p3l220t1812r800b1913],
66	dependent	JJ	O	dependent	dep	168	SENT_20	[p3l220t1812r800b1913],
67	clotting	NN	O	clotting	dep	168	SENT_20	[p3l831t1812r1176b1913],
68	factors	NNS	O	factor	dep	168	SENT_20	[p3l1208t1812r1505b1891],
69	11	CD	NUMBER	11	dep	168	SENT_20	[p3l1540t1820r1607b1890],
70	(	NN	O	(	dep	168	SENT_20	[p3l1646t1812r2132b1913],
71	prothrom	NN	O	prothrom	dep	168	SENT_20	[p3l1646t1812r2132b1913],
72	—	CD	NUMBER	—	dep	168	SENT_20	[p3l1646t1812r2132b1913],
73	bin	NN	O	bin	dep	168	SENT_20	[p3l12t1940r194b2036],
74	)	NN	O	)	dep	168	SENT_20	[p3l12t1940r194b2036],
75	,	,	O	,	_	0	SENT_20	[p3l12t1940r194b2036],
76	VII	NN	O	vii	dep	168	SENT_20	[p3l232t1948r386b2036],
77	,	,	O	,	_	0	SENT_20	[p3l232t1948r386b2036],
78	IX	CD	NUMBER	ix	dep	168	SENT_20	[p3l427t1948r544b2036],
79	,	,	O	,	_	0	SENT_20	[p3l427t1948r544b2036],
80	and	CC	O	and	dep	168	SENT_20	[p3l586t1940r744b2019],
81	X.	NNP	O	X.	dep	168	SENT_20	[p3l777t1948r860b2019],
82	Studies	NNS	O	study	dep	168	SENT_20	[p3l905t1940r1212b2019],
83	have	VBP	O	have	dep	168	SENT_20	[p3l1250t1940r1440b2019],
84	shown	VBN	O	show	dep	168	SENT_20	[p3l1479t1940r1760b2019],
85	that	IN	O	that	dep	168	SENT_20	[p3l1798t1940r1970b2019],
86	patients	NNS	O	patient	dep	168	SENT_20	[p3l2001t1966r2132b2041, p3l12t2069r242b2147],
87	with	IN	O	with	dep	168	SENT_20	[p3l274t2068r465b2148],
88	CYP2C9	NN	O	cyp2c9	dep	168	SENT_20	[p3l499t2072r881b2146],
89	‘	CD	NUMBER	‘	dep	168	SENT_20	[p3l499t2072r881b2146],
90	*	CD	NUMBER	*	dep	168	SENT_20	[p3l499t2072r881b2146],
91	’	NN	O	’	dep	168	SENT_20	[p3l499t2072r881b2146],
92	2	CD	NUMBER	2	dep	168	SENT_20	[p3l499t2072r881b2146],
93	and	CC	O	and	dep	168	SENT_20	[p3l915t2068r1071b2147],
94	CYP2C9	NN	O	cyp2c9	dep	168	SENT_20	[p3l1104t2072r1485b2146],
95	‘	CD	NUMBER	‘	dep	168	SENT_20	[p3l1104t2072r1485b2146],
96	*	CD	NUMBER	*	dep	168	SENT_20	[p3l1104t2072r1485b2146],
97	’	NN	O	’	dep	168	SENT_20	[p3l1104t2072r1485b2146],
98	3	CD	NUMBER	3	dep	168	SENT_20	[p3l1104t2072r1485b2146],
99	allelic	JJ	O	allelic	dep	168	SENT_20	[p3l1520t2068r1767b2147],
100	variants	NNS	O	variant	dep	168	SENT_20	[p3l1795t2069r2131b2148],
101	and	CC	O	and	dep	168	SENT_20	[p3l11t2196r166b2275],
102	the	DT	O	the	dep	168	SENT_20	[p3l202t2196r332b2275],
103	VKORCI	NNP	O	VKORCI	dep	168	SENT_20	[p3l366t2203r683b2276],
104	haplotype	NN	O	haplotype	dep	168	SENT_20	[p3l721t2196r1137b2297],
105	A/A	NN	O	a/a	dep	168	SENT_20	[p3l1169t2201r1324b2286],
106	require	VBP	O	require	dep	168	SENT_20	[p3l1356t2197r1655b2297],
107	lower	JJR	O	lower	dep	168	SENT_20	[p3l1689t2196r1922b2275],
108	doses	NNS	O	dose	dep	168	SENT_20	[p3l1955t2196r2132b2275, p3l12t2351r95b2403],
109	of	IN	O	of	dep	168	SENT_20	[p3l136t2324r236b2403],
110	warfarin	NN	O	warfarin	dep	168	SENT_20	[p3l252t2324r626b2404],
111	to	TO	O	to	dep	168	SENT_20	[p3l666t2341r747b2403],
112	achieve	VB	O	achieve	dep	168	SENT_20	[p3l787t2324r1098b2403],
113	an	DT	O	a	dep	168	SENT_20	[p3l1137t2350r1239b2403],
114	appropriate	JJ	O	appropriate	dep	168	SENT_20	[p3l1277t2325r1772b2425],
115	state	NN	O	state	dep	168	SENT_20	[p3l1813t2341r2012b2403],
116	of	IN	O	of	dep	168	SENT_20	[p3l2051t2324r2151b2403],
117	anticoagulation	NN	O	anticoagulation	dep	168	SENT_20	[p3l11t2452r705b2553],
118	with	IN	O	with	dep	168	SENT_20	[p3l751t2452r950b2531],
119	a	DT	O	a	dep	168	SENT_20	[p3l1000t2479r1044b2531],
120	minimal	JJ	O	minimal	dep	168	SENT_20	[p3l1093t2452r1471b2531],
121	risk	NN	O	risk	dep	168	SENT_20	[p3l1521t2452r1689b2532],
122	of	IN	O	of	dep	168	SENT_20	[p3l1736t2452r1836b2531],
123	bleeding	VBG	O	bleed	dep	168	SENT_20	[p3l1869t2452r2132b2531, p3l11t2581r275b2681],
124	.3	NN	NUMBER	.3	dep	168	SENT_20	[p3l1869t2452r2132b2531, p3l11t2581r275b2681],
125	»	NN	O	»	dep	168	SENT_20	[p3l1869t2452r2132b2531, p3l11t2581r275b2681],
126	4	CD	NUMBER	4	dep	168	SENT_20	[p3l1869t2452r2132b2531, p3l11t2581r275b2681],
127	In	IN	O	in	dep	168	SENT_20	[p3l317t2588r407b2658],
128	August	NNP	DATE	August	dep	168	SENT_20	[p3l448t2588r763b2681],
129	2007	CD	DATE	2007	dep	168	SENT_20	[p3l802t2586r1025b2676],
130	,	,	O	,	_	0	SENT_20	[p3l802t2586r1025b2676],
131	the	DT	O	the	dep	168	SENT_20	[p3l1075t2580r1210b2659],
132	Food	NNP	ORGANIZATION	Food	dep	168	SENT_20	[p3l1254t2580r1471b2659],
133	and	CC	ORGANIZATION	and	dep	168	SENT_20	[p3l1515t2580r1675b2659],
134	Drug	NNP	ORGANIZATION	Drug	dep	168	SENT_20	[p3l1718t2587r1942b2681],
135	Administration	NNP	ORGANIZATION	Administration	dep	168	SENT_20	[p3l1980t2580r2132b2659, p3l11t2710r544b2788],
136	(	CD	NUMBER	(	dep	168	SENT_20	[p3l581t2716r812b2801],
137	FDA	NNP	ORGANIZATION	FDA	dep	168	SENT_20	[p3l581t2716r812b2801],
138	)	CD	NUMBER	)	dep	168	SENT_20	[p3l581t2716r812b2801],
139	deemed	VBD	O	deem	dep	168	SENT_20	[p3l850t2709r1175b2788],
140	that	IN	O	that	dep	168	SENT_20	[p3l1207t2709r1375b2788],
141	the	DT	O	the	dep	168	SENT_20	[p3l1402t2709r1532b2788],
142	accumulation	NN	O	accumulation	dep	168	SENT_20	[p3l1564t2709r2133b2789],
143	of	IN	O	of	dep	168	SENT_20	[p3l12t2837r112b2916],
144	pharmacogenomic	JJ	O	pharmacogenomic	dep	168	SENT_20	[p3l127t2837r937b2938],
145	information	NN	O	information	dep	168	SENT_20	[p3l971t2837r1494b2916],
146	was	VBD	O	be	dep	168	SENT_20	[p3l1525t2864r1688b2916],
147	sufficient	JJ	O	sufficient	dep	168	SENT_20	[p3l1727t2837r2138b2916],
148	to	TO	O	to	dep	168	SENT_20	[p3l12t2982r92b3044],
149	warrant	VB	O	warrant	dep	168	SENT_20	[p3l127t2982r464b3045],
150	a	DT	O	a	dep	168	SENT_20	[p3l496t2992r540b3044],
151	modification	NN	O	modification	dep	168	SENT_20	[p3l577t2965r1127b3044],
152	in	IN	O	in	dep	168	SENT_20	[p3l1164t2966r1246b3043],
153	the	DT	O	the	dep	168	SENT_20	[p3l1284t2965r1415b3044],
154	labeling	NN	O	labeling	dep	168	SENT_20	[p3l1452t2965r1795b3066],
155	of	IN	O	of	dep	168	SENT_20	[p3l1831t2965r1929b3044],
156	warfarin	NN	O	warfarin	dep	168	SENT_20	[p3l1944t2991r2132b3044, p3l11t3093r218b3172],
157	to	TO	O	to	dep	168	SENT_20	[p3l262t3110r343b3172],
158	highlight	VB	O	highlight	dep	168	SENT_20	[p3l388t3093r791b3194],
159	the	DT	O	the	dep	168	SENT_20	[p3l830t3093r963b3172],
160	potential	JJ	O	potential	dep	168	SENT_20	[p3l1005t3093r1394b3194],
161	relevance	NN	O	relevance	dep	168	SENT_20	[p3l1436t3093r1833b3172],
162	of	IN	O	of	dep	168	SENT_20	[p3l1877t3093r1977b3172],
163	genetic	JJ	O	genetic	dep	168	SENT_20	[p3l2002t3120r2132b3194, p3l11t3222r219b3300],
164	information	NN	O	information	dep	168	SENT_20	[p3l255t3221r778b3300],
165	to	TO	O	to	dep	168	SENT_20	[p3l817t3238r898b3300],
166	prescribing	VBG	O	prescribe	dep	168	SENT_20	[p3l936t3221r1429b3322],
167	decisions	NNS	O	decision	dep	168	SENT_20	[p3l1463t3221r1920b3300],
168	.5	CD	NUMBER	.5	_	0	SENT_20	[p3l1463t3221r1920b3300],

1	The	DT	O	the	det	2	SENT_21	[p3l137t3349r297b3428],
2	study	NN	O	study	_	0	SENT_21	[p3l349t3349r578b3450],
3	by	IN	O	by	_	0	SENT_21	[p3l623t3349r721b3450],
4	Schwarz	NNP	PERSON	Schwarz	prep_by	2	SENT_21	[p3l768t3349r1125b3428],
5	et	FW	O	et	nn	6	SENT_21	[p3l1175t3366r1252b3428],
6	al.	FW	O	al.	dep	2	SENT_21	[p3l1296t3349r1393b3428],
7	in	IN	O	in	_	0	SENT_21	[p3l1447t3350r1530b3427],
8	this	DT	O	this	det	9	SENT_21	[p3l1580t3349r1739b3428],
9	issue	NN	O	issue	prep_in	6	SENT_21	[p3l1791t3350r2001b3428],
10	of	IN	O	of	prep	9	SENT_21	[p3l2052t3349r2152b3428],

1	N	NN	O	n	nn	3	SENT_22	[p3l525t3519r539b3534],
2	ENGLJ	NN	O	englj	nn	3	SENT_22	[p3l553t3519r631b3541],
3	MED	NN	O	med	_	0	SENT_22	[p3l646t3519r698b3534],
4	358	CD	NUMBER	358	num	6	SENT_22	[p3l708t3513r785b3541],
5	;	:	O	;	_	0	SENT_22	[p3l708t3513r785b3541],
6	1o	CD	NUMBER	1o	dep	3	SENT_22	[p3l708t3513r785b3541],
7	WWW.NEJM.oRG	NNP	O	WWW.NEJM.oRG	nn	8	SENT_22	[p3l818t3519r1019b3541],
8	MARCH	NNP	DATE	MARCH	dep	3	SENT_22	[p3l1056t3519r1141b3535],
9	6,2008	CD	DATE	6,2008	number	10	SENT_22	[p3l1154t3513r1249b3539],
10	1061	CD	DATE	1061	dep	8	SENT_22	[p3l1940t3508r2016b3531],

1	Th	NN	O	th	dep	21	SENT_23	[p3l672t3740r703b3761],
2	e	SYM	O	e	dep	6	SENT_23	[p3l709t3747r717b3761],
3	N	NN	O	n	nn	6	SENT_23	[p3l736t3742r759b3761],
4	E	NN	O	e	nn	6	SENT_23	[p3l768t3742r785b3761],
5	W	NN	O	w	nn	6	SENT_23	[p3l791t3742r821b3761],
6	E	NN	O	e	rcmod	1	SENT_23	[p3l840t3742r857b3761],
7	N	NN	O	n	prep	1	SENT_23	[p3l865t3742r889b3761],
8	G	NN	O	g	nn	11	SENT_23	[p3l896t3742r918b3761],
9	L	NN	O	l	nn	11	SENT_23	[p3l924t3742r941b3761],
10	A	NN	O	a	nn	11	SENT_23	[p3l947t3742r968b3761],
11	ND	NN	O	nd	dep	7	SENT_23	[p3l975t3742r1060b3768],
12	]	CD	NUMBER	]	num	13	SENT_23	[p3l975t3742r1060b3768],
13	O	NN	O	o	dep	21	SENT_23	[p3l1067t3742r1088b3761],
14	U	NNP	O	U	nn	21	SENT_23	[p3l1095t3742r1117b3761],
15	R	NNP	O	R	nn	21	SENT_23	[p3l1125t3742r1147b3761],
16	N	NNP	O	N	nn	21	SENT_23	[p3l1154t3742r1178b3761],
17	A	NNP	O	A	nn	21	SENT_23	[p3l1183t3742r1204b3761],
18	Laf	NN	O	laf	nn	21	SENT_23	[p3l1211t3740r1276b3767],
19	M	NN	O	m	nn	21	SENT_23	[p3l1287t3742r1314b3761],
20	E	NN	O	e	nn	21	SENT_23	[p3l1323t3742r1340b3761],
21	D	NN	O	d	dep	25	SENT_23	[p3l1347t3742r1369b3761],
22	I	PRP	O	I	dep	21	SENT_23	[p3l1376t3742r1386b3761],
23	C	NN	O	c	prep	22	SENT_23	[p3l1394t3742r1412b3761],
24	I	PRP	O	I	dep	23	SENT_23	[p3l1419t3742r1430b3761],
25	NE	NNS	O	ne	_	0	SENT_23	[p3l1438t3742r1487b3761],

1	the	DT	O	the	det	2	SENT_24	[p4l21t167r154b245],
2	journal	NN	O	journal	nsubj	3	SENT_24	[p4l176t167r465b267],
3	adds	VBZ	O	add	_	0	SENT_24	[p4l502t167r695b245],
4	to	TO	O	to	_	0	SENT_24	[p4l737t184r817b245],
5	these	DT	O	these	det	6	SENT_24	[p4l858t167r1080b245],
6	observations	NNS	O	observation	prep_to	3	SENT_24	[p4l1120t167r1661b246],
7	by	IN	O	by	_	0	SENT_24	[p4l1702t167r1799b267],
8	providing	VBG	O	provide	prepc_by	3	SENT_24	[p4l1831t167r2134b267, p4l20t295r160b394],
9	important	JJ	O	important	amod	11	SENT_24	[p4l194t295r642b394],
10	prospective	JJ	O	prospective	amod	11	SENT_24	[p4l674t295r1172b394],
11	data	NNS	O	datum	dobj	8	SENT_24	[p4l1211t294r1396b372],
12	on	IN	O	on	_	0	SENT_24	[p4l1433t320r1540b372],
13	variability	NN	O	variability	prep_on	8	SENT_24	[p4l1573t294r2018b394],
14	in	IN	O	in	_	0	SENT_24	[p4l2051t295r2135b371],
15	the	DT	O	the	det	17	SENT_24	[p4l21t421r156b499],
16	INR	NN	O	inr	nn	17	SENT_24	[p4l198t428r383b504],
17	response	NN	O	response	prep_in	13	SENT_24	[p4l415t447r795b521],
18	to	TO	O	to	_	0	SENT_24	[p4l837t438r918b499],
19	initial	JJ	O	initial	amod	21	SENT_24	[p4l962t421r1218b499],
20	Warfarin	NN	O	warfarin	nn	21	SENT_24	[p4l1255t421r1628b500],
21	therapy	NN	O	therapy	prep_to	8	SENT_24	[p4l1671t421r1991b521],
22	on	IN	O	on	_	0	SENT_24	[p4l2030t447r2135b499],
23	the	DT	O	the	det	24	SENT_24	[p4l21t548r154b626],
24	basis	NN	O	basis	prep_on	21	SENT_24	[p4l190t548r396b626],
25	of	IN	O	of	_	0	SENT_24	[p4l432t548r530b626],
26	CYPZC9	NN	O	cypzc9	nn	27	SENT_24	[p4l545t555r835b626],
27	genotypes	NNS	O	genotype	prep_of	24	SENT_24	[p4l868t565r1294b648],
28	and	CC	O	and	_	0	SENT_24	[p4l1329t548r1484b626],
29	VKORCI	NN	O	vkorcus	nn	30	SENT_24	[p4l1516t555r1832b627],
30	haplotypes	NNS	O	haplotype	conj_and	27	SENT_24	[p4l1868t548r2134b648, p4l21t679r304b775],
31	.	.	O	.	_	0	SENT_24	[p4l1868t548r2134b648, p4l21t679r304b775],

1	‘	NN	O	‘	_	0	SENT_25	[p4l1868t548r2134b648, p4l21t679r304b775],
2	5	CD	NUMBER	5	num	1	SENT_25	[p4l1868t548r2134b648, p4l21t679r304b775],
3	The	DT	O	the	det	4	SENT_25	[p4l342t675r500b753],
4	investigators	NNS	O	investigator	nsubj	5	SENT_25	[p4l540t676r1073b775],
5	examined	VBD	O	examine	rcmod	1	SENT_25	[p4l1116t675r1527b753],
6	the	DT	O	the	det	7	SENT_25	[p4l1567t675r1697b753],
7	effects	NNS	O	effect	dobj	5	SENT_25	[p4l1738t675r2012b753],
8	of	IN	O	of	_	0	SENT_25	[p4l2055t675r2153b753],
9	variants	NNS	O	variant	prep_of	7	SENT_25	[p4l16t804r358b882],
10	of	IN	O	of	_	0	SENT_25	[p4l402t803r502b882],
11	CYPZC9	NN	O	cypzc9	prep_of	9	SENT_25	[p4l525t810r819b881],
12	and	CC	O	and	_	0	SENT_25	[p4l859t803r1016b882],
13	VKORC1	NN	O	vkorc1	conj_and	11	SENT_25	[p4l1056t810r1377b883],
14	on	IN	O	on	_	0	SENT_25	[p4l1422t829r1527b882],
15	initial	JJ	O	initial	amod	16	SENT_25	[p4l1567t803r1823b882],
16	warfarin	NN	O	warfarin	prep_on	5	SENT_25	[p4l1859t803r2134b883, p4l21t931r142b1007],

1	dose	NN	O	dose	nn	2	SENT_26	[p4l180t930r370b1008],
2	requirements	NNS	O	requirement	_	0	SENT_26	[p4l406t931r963b1030],
3	in	IN	O	in	_	0	SENT_26	[p4l1000t931r1082b1007],
4	a	DT	O	a	det	5	SENT_26	[p4l1117t957r1161b1008],
5	cohort	NN	O	cohort	prep_in	2	SENT_26	[p4l1196t930r1471b1008],
6	of	IN	O	of	_	0	SENT_26	[p4l1502t930r1601b1008],
7	297	CD	NUMBER	297	num	8	SENT_26	[p4l1617t936r1765b1008],
8	patients	NNS	O	patient	prep_of	5	SENT_26	[p4l1801t931r2133b1030],
9	Who	WP	O	who	nsubj	11	SENT_26	[p4l16t1057r197b1136],
10	were	VBD	O	be	aux	11	SENT_26	[p4l228t1083r426b1136],
11	undergoing	VBG	O	undergo	rcmod	8	SENT_26	[p4l459t1057r949b1157],
12	anticoagulation	NN	O	anticoagulation	nn	13	SENT_26	[p4l978t1057r1640b1157],
13	therapy	NN	O	therapy	dobj	11	SENT_26	[p4l1674t1057r1989b1157],
14	for	IN	O	for	_	0	SENT_26	[p4l2017t1057r2138b1135],
15	a	DT	O	a	det	16	SENT_26	[p4l20t1211r64b1262],
16	variety	NN	O	variety	prep_for	11	SENT_26	[p4l94t1185r383b1284],
17	of	IN	O	of	_	0	SENT_26	[p4l415t1184r515b1262],
18	typical	JJ	O	typical	amod	19	SENT_26	[p4l532t1184r818b1284],
19	indications	NNS	O	indication	prep_of	16	SENT_26	[p4l852t1184r1354b1262],
20	.	.	O	.	_	0	SENT_26	[p4l852t1184r1354b1262],

1	The	DT	O	the	det	2	SENT_27	[p4l1391t1184r1552b1262],
2	investigators	NNS	O	investigator	nsubj	3	SENT_27	[p4l1586t1185r2133b1284],
3	found	VBD	O	find	_	0	SENT_27	[p4l21t1311r272b1390],
4	that	IN	O	that	complm	14	SENT_27	[p4l323t1311r495b1389],
5	the	DT	O	the	det	8	SENT_27	[p4l542t1311r674b1389],
6	early	JJ	O	early	amod	8	SENT_27	[p4l726t1311r931b1411],
7	INR	NN	O	inr	nn	8	SENT_27	[p4l976t1318r1161b1394],
8	response	NN	O	response	nsubjpass	14	SENT_27	[p4l1202t1337r1581b1411],
9	to	TO	O	to	_	0	SENT_27	[p4l1633t1328r1714b1389],
10	Warfarin	NNP	MISC	Warfarin	prep_to	8	SENT_27	[p4l1762t1311r2135b1390],
11	Was	VBD	MISC	be	auxpass	14	SENT_27	[p4l16t1465r178b1517],
12	more	RBR	O	more	advmod	13	SENT_27	[p4l221t1464r439b1516],
13	strongly	RB	O	strongly	advmod	14	SENT_27	[p4l481t1438r832b1538],
14	inﬂuenced	VBN	O	inﬂuenced	ccomp	3	SENT_27	[p4l868t1438r1327b1517],
15	by	IN	O	by	_	0	SENT_27	[p4l1367t1438r1463b1538],
16	VKORC1	NN	O	vkorc1	nn	17	SENT_27	[p4l1499t1445r1820b1517],
17	haplotypes	NNS	O	haplotype	agent	14	SENT_27	[p4l1863t1438r2134b1538, p4l21t1581r241b1665],
18	than	IN	O	than	prep	14	SENT_27	[p4l282t1565r475b1643],
19	by	IN	O	by	pcomp	18	SENT_27	[p4l514t1565r610b1665],
20	CYPZC9	NN	O	cypzc9	nn	21	SENT_27	[p4l644t1572r934b1643],
21	genotypes	NNS	O	genotype	pobj	19	SENT_27	[p4l972t1582r1422b1665],
22	.	.	O	.	_	0	SENT_27	[p4l972t1582r1422b1665],

1	Specifically	RB	O	specifically	advmod	9	SENT_28	[p4l1469t1565r1962b1665],
2	,	,	O	,	_	0	SENT_28	[p4l1469t1565r1962b1665],
3	patients	NNS	O	patient	nsubj	9	SENT_28	[p4l2005t1591r2134b1665, p4l21t1693r262b1770],
4	with	IN	O	with	_	0	SENT_28	[p4l322t1692r519b1771],
5	the	DT	O	the	det	8	SENT_28	[p4l581t1692r715b1770],
6	AIA	NNP	ORGANIZATION	AIA	nn	8	SENT_28	[p4l774t1697r933b1781],
7	VKORCI	NNP	O	VKORCI	nn	8	SENT_28	[p4l990t1699r1317b1771],
8	haplotype	NN	O	haplotype	prep_with	3	SENT_28	[p4l1381t1692r1812b1792],
9	had	VBD	O	have	_	0	SENT_28	[p4l1874t1692r2032b1770],
10	a	DT	O	a	det	12	SENT_28	[p4l2093t1719r2137b1770],
11	decreased	VBN	O	decrease	amod	12	SENT_28	[p4l21t1820r442b1899],
12	time	NN	O	time	dobj	9	SENT_28	[p4l476t1821r668b1899],
13	to	TO	O	to	_	0	SENT_28	[p4l702t1837r783b1899],
14	the	DT	O	the	det	17	SENT_28	[p4l819t1820r950b1899],
15	first	JJ	ORDINAL	first	amod	17	SENT_28	[p4l985t1820r1168b1899],
16	IN	IN	O	in	amod	17	SENT_28	[p4l1194t1828r1304b1899],
17	R	NN	O	r	prep_to	12	SENT_28	[p4l1307t1827r1380b1904],
18	within	IN	O	within	_	0	SENT_28	[p4l1399t1820r1683b1900],
19	the	DT	O	the	det	21	SENT_28	[p4l1716t1820r1849b1899],
20	therapeutic	JJ	O	therapeutic	amod	21	SENT_28	[p4l1883t1820r2134b1899, p4l20t1948r282b2047],
21	range	NN	O	range	prep_within	17	SENT_28	[p4l325t1973r565b2047],
22	and	CC	O	and	_	0	SENT_28	[p4l608t1947r765b2025],
23	to	TO	O	to	_	0	SENT_28	[p4l810t1964r891b2025],
24	an	DT	O	a	det	25	SENT_28	[p4l936t1973r1038b2025],
25	INR	NN	O	inr	prep_to	12	SENT_28	[p4l1081t1954r1266b2030],
26	of	IN	O	of	_	0	SENT_28	[p4l1301t1947r1400b2025],
27	more	JJR	O	more	mwe	28	SENT_28	[p4l1426t1973r1644b2025],
28	than	IN	O	than	quantmod	29	SENT_28	[p4l1689t1947r1885b2025],
29	4	CD	NUMBER	4	prep_of	25	SENT_28	[p4l1927t1953r1999b2042],
30	,	,	O	,	_	0	SENT_28	[p4l1927t1953r1999b2042],
31	as	IN	O	as	advmod	9	SENT_28	[p4l2047t1974r2133b2025],
32	compared	VBN	O	compare	_	0	SENT_28	[p4l21t2074r439b2174],
33	with	IN	O	with	prepc_compared_with	9	SENT_28	[p4l467t2074r659b2153],
34	patients	NNS	O	patient	pobj	9	SENT_28	[p4l690t2075r1023b2174],
35	who	WP	O	who	nsubj	38	SENT_28	[p4l1054t2074r1234b2153],
36	did	VBD	O	do	aux	38	SENT_28	[p4l1270t2074r1401b2152],
37	not	RB	O	not	neg	38	SENT_28	[p4l1435t2091r1575b2152],
38	have	VB	O	have	rcmod	34	SENT_28	[p4l1603t2074r1788b2153],
39	the	DT	O	the	det	41	SENT_28	[p4l1823t2074r1953b2152],
40	AIA	NNP	ORGANIZATION	AIA	nn	41	SENT_28	[p4l1983t2079r2138b2163],
41	haplotype	NN	O	haplotype	dobj	38	SENT_28	[p4l21t2201r457b2301],
42	.	.	O	.	_	0	SENT_28	[p4l21t2201r457b2301],

1	In	IN	O	in	_	0	SENT_29	[p4l500t2209r588b2278],
2	contrast	NN	O	contrast	prep_in	8	SENT_29	[p4l627t2218r990b2296],
3	,	,	O	,	_	0	SENT_29	[p4l627t2218r990b2296],
4	CYPZC9	NN	O	cypzc9	nn	5	SENT_29	[p4l1035t2208r1323b2279],
5	genotypes	NNS	O	genotype	nsubj	8	SENT_29	[p4l1362t2218r1788b2301],
6	did	VBD	O	do	aux	8	SENT_29	[p4l1829t2201r1962b2279],
7	not	RB	O	not	neg	8	SENT_29	[p4l2000t2218r2140b2279],
8	affect	VB	O	affect	_	0	SENT_29	[p4l20t2329r265b2408],
9	the	DT	O	the	det	10	SENT_29	[p4l296t2329r428b2408],
10	time	NN	O	time	dep	8	SENT_29	[p4l464t2330r656b2408],
11	to	TO	O	to	_	0	SENT_29	[p4l692t2346r773b2408],
12	the	DT	O	the	det	14	SENT_29	[p4l810t2329r943b2408],
13	first	JJ	ORDINAL	first	amod	14	SENT_29	[p4l978t2329r1162b2408],
14	INR	NNP	O	INR	prep_to	10	SENT_29	[p4l1190t2336r1376b2413],
15	Within	IN	O	within	dep	10	SENT_29	[p4l1396t2329r1680b2409],
16	the	DT	O	the	det	18	SENT_29	[p4l1716t2329r1848b2408],
17	therapeutic	JJ	O	therapeutic	amod	18	SENT_29	[p4l1884t2329r2134b2408, p4l20t2457r282b2556],
18	range	NN	O	range	pobj	15	SENT_29	[p4l318t2482r557b2556],
19	but	CC	O	but	_	0	SENT_29	[p4l594t2456r733b2535],
20	did	VBD	O	do	aux	21	SENT_29	[p4l765t2456r900b2534],
21	predict	VB	O	predict	conj_but	8	SENT_29	[p4l935t2456r1237b2556],
22	the	DT	O	the	det	23	SENT_29	[p4l1269t2456r1401b2534],
23	time	NN	O	time	dobj	21	SENT_29	[p4l1438t2457r1630b2534],
24	to	TO	O	to	_	0	SENT_29	[p4l1668t2472r1748b2534],
25	the	DT	O	the	det	27	SENT_29	[p4l1787t2456r1919b2534],
26	first	JJ	ORDINAL	first	amod	27	SENT_29	[p4l1956t2456r2140b2534],
27	INR	NN	O	inr	prep_to	21	SENT_29	[p4l20t2590r203b2666],
28	of	IN	O	of	_	0	SENT_29	[p4l229t2583r327b2661],
29	more	JJR	O	more	mwe	30	SENT_29	[p4l346t2609r561b2661],
30	than	IN	O	than	quantmod	31	SENT_29	[p4l598t2583r791b2661],
31	4	CD	NUMBER	4	prep_of	27	SENT_29	[p4l825t2589r895b2661],
32	.	.	O	.	_	0	SENT_29	[p4l825t2589r895b2661],

1	Variants	NNS	O	variant	nsubjpass	6	SENT_30	[p4l934t2584r1280b2661],
2	of	IN	O	of	_	0	SENT_30	[p4l1319t2583r1418b2661],
3	both	DT	O	both	det	4	SENT_30	[p4l1436t2583r1630b2661],
4	genes	NNS	O	gene	prep_of	1	SENT_30	[p4l1666t2609r1903b2683],
5	were	VBD	O	be	auxpass	6	SENT_30	[p4l1937t2609r2134b2662],
6	associated	VBN	O	associate	conj_negcc	6	SENT_30	[p4l20t2710r454b2788],
7	with	IN	O	with	_	0	SENT_30	[p4l487t2710r678b2789],
8	Warfarin	NNP	O	Warfarin	nn	10	SENT_30	[p4l711t2710r1077b2789],
9	dose	NN	O	dose	nn	10	SENT_30	[p4l1116t2710r1306b2788],
10	requirements	NNS	O	requirement	prep_with	6	SENT_30	[p4l1344t2711r1901b2810],
11	after	IN	O	after	_	0	SENT_30	[p4l1941t2710r2138b2788],
12	the	DT	DURATION	the	det	15	SENT_30	[p4l21t2837r154b2915],
13	initial	JJ	DURATION	initial	amod	15	SENT_30	[p4l201t2837r457b2915],
14	2	CD	DURATION	2	num	15	SENT_30	[p4l503t2843r551b2914],
15	weeks	NNS	NUMBER	week	prep_after	6	SENT_30	[p4l594t2837r854b2916],
16	of	IN	O	of	_	0	SENT_30	[p4l905t2837r1004b2915],
17	therapy	NN	O	therapy	prep_of	15	SENT_30	[p4l1034t2837r1355b2937],
18	but	CC	O	but	_	0	SENT_30	[p4l1399t2837r1538b2916],
19	not	RB	O	not	_	0	SENT_30	[p4l1580t2854r1723b2915],
20	with	IN	O	with	_	0	SENT_30	[p4l1761t2837r1955b2916],
21	the	DT	O	the	det	22	SENT_30	[p4l2003t2837r2135b2915],
22	incidence	NN	O	incidence	prep_with	6	SENT_30	[p4l20t2964r424b3042],
23	of	IN	O	of	_	0	SENT_30	[p4l463t2964r562b3042],
24	bleeding	VBG	O	bleed	amod	25	SENT_30	[p4l583t2964r953b3064],
25	episodes	NNS	O	episode	prep_of	22	SENT_30	[p4l988t2964r1379b3064],
26	.	.	O	.	_	0	SENT_30	[p4l988t2964r1379b3064],

1	These	DT	O	these	det	2	SENT_31	[p4l146t3091r397b3169],
2	findings	NNS	O	finding	nsubj	3	SENT_31	[p4l434t3091r796b3191],
3	add	VBP	O	add	_	0	SENT_31	[p4l835t3091r987b3169],
4	important	JJ	O	important	amod	5	SENT_31	[p4l1023t3092r1463b3191],
5	information	NN	O	information	dobj	3	SENT_31	[p4l1494t3091r2016b3169],
6	to	TO	O	to	_	0	SENT_31	[p4l2053t3108r2134b3169],
7	the	DT	O	the	det	8	SENT_31	[p4l21t3218r154b3296],
8	body	NN	O	body	prep_to	3	SENT_31	[p4l203t3218r412b3318],
9	of	IN	O	of	_	0	SENT_31	[p4l456t3218r556b3296],
10	knowledge	NN	O	knowledge	prep_of	8	SENT_31	[p4l585t3218r1051b3318],
11	about	IN	O	about	_	0	SENT_31	[p4l1099t3218r1341b3297],
12	the	DT	O	the	det	15	SENT_31	[p4l1386t3218r1518b3296],
13	pharmacoge	NN	O	pharmacoge	nn	15	SENT_31	[p4l1565t3218r2134b3318],
14	—	NN	O	—	nn	15	SENT_31	[p4l1565t3218r2134b3318],
15	netics	NNS	O	netic	prep_about	10	SENT_31	[p4l21t3346r274b3423],
16	of	IN	O	of	_	0	SENT_31	[p4l314t3345r415b3423],
17	Warfarin	NNP	MISC	Warfarin	prep_of	15	SENT_31	[p4l429t3345r834b3440],
18	,	,	O	,	_	0	SENT_31	[p4l429t3345r834b3440],
19	but	CC	O	but	_	0	SENT_31	[p4l877t3345r1019b3424],
20	they	PRP	O	they	nsubj	22	SENT_31	[p4l1051t3345r1236b3445],
21	also	RB	O	also	advmod	22	SENT_31	[p4l1268t3345r1442b3423],
22	remind	VBP	O	remind	conj_but	3	SENT_31	[p4l1481t3345r1796b3423],
23	us	PRP	O	we	dobj	22	SENT_31	[p4l1833t3372r1926b3424],
24	that	IN	O	that	complm	28	SENT_31	[p4l1965t3345r2140b3423],
25	the	DT	O	the	det	27	SENT_31	[p4l21t3472r154b3550],
26	Warfarin	NNP	O	Warfarin	nn	27	SENT_31	[p4l197t3472r570b3551],
27	story	NN	O	story	nsubj	28	SENT_31	[p4l618t3489r832b3572],
28	is	VBZ	O	be	ccomp	22	SENT_31	[p4l874t3473r939b3550],
29	far	RB	O	far	_	0	SENT_31	[p4l988t3472r1108b3550],
30	from	IN	O	from	_	0	SENT_31	[p4l1152t3472r1362b3550],
31	complete	JJ	O	complete	prep_far_from	28	SENT_31	[p4l1409t3472r1819b3572],
32	.	.	O	.	_	0	SENT_31	[p4l1409t3472r1819b3572],

1	Fortunately	RB	O	fortunately	advmod	6	SENT_32	[p4l1870t3480r2134b3551, p4l21t3599r290b3699],
2	,	,	O	,	_	0	SENT_32	[p4l1870t3480r2134b3551, p4l21t3599r290b3699],
3	much	JJ	O	much	amod	5	SENT_32	[p4l335t3599r573b3678],
4	basic	JJ	O	basic	amod	5	SENT_32	[p4l613t3599r826b3677],
5	research	NN	O	research	nsubj	6	SENT_32	[p4l865t3599r1226b3677],
6	is	VBZ	O	be	_	0	SENT_32	[p4l1265t3600r1331b3677],
7	under	IN	O	under	_	0	SENT_32	[p4l1372t3599r1622b3678],
8	way	NN	O	way	prep_under	6	SENT_32	[p4l1654t3626r1822b3699],
9	to	TO	O	to	aux	10	SENT_32	[p4l1857t3616r1938b3677],
10	elucidate	VB	O	elucidate	xcomp	6	SENT_32	[p4l1980t3599r2134b3678, p5l21t20r271b98],

1	the	DT	O	the	det	2	SENT_33	[p5l314t20r446b98],
2	pathways	NNS	O	pathway	conj_or	2	SENT_33	[p5l486t20r884b120],
3	by	IN	O	by	_	0	SENT_33	[p5l928t20r1025b120],
4	which	WDT	O	which	dobj	10	SENT_33	[p5l1058t20r1319b99],
5	CYPZCP	NN	O	cypzcp	nn	6	SENT_33	[p5l1361t27r1661b97],
6	genotypes	NNS	O	genotype	nsubj	10	SENT_33	[p5l1698t36r2133b120],
7	and	CC	O	and	_	0	SENT_33	[p5l20t147r179b225],
8	VKORC1	NN	O	vkorc1	nn	9	SENT_33	[p5l233t154r560b227],
9	haplotypes	NNS	O	haplotype	nsubj	10	SENT_33	[p5l617t147r1092b247],
10	—	CD	NUMBER	—	prepc_by	2	SENT_33	[p5l1144t192r1251b200],
11	acting	VBG	O	act	partmod	10	SENT_33	[p5l1301t148r1574b247],
12	alone	RB	O	alone	advmod	11	SENT_33	[p5l1624t147r1882b242],
13	,	,	O	,	_	0	SENT_33	[p5l1624t147r1882b242],
14	with	IN	O	with	dep	10	SENT_33	[p5l1937t147r2135b226],
15	other	JJ	O	other	amod	16	SENT_33	[p5l21t274r244b352],
16	genes	NNS	O	gene	pobj	14	SENT_33	[p5l275t300r535b374],
17	,	,	O	,	_	0	SENT_33	[p5l275t300r535b374],
18	or	CC	O	or	_	0	SENT_33	[p5l575t300r663b352],
19	in	IN	O	in	_	0	SENT_33	[p5l693t275r775b351],
20	combination	NN	O	combination	prep_in	2	SENT_33	[p5l810t274r1344b352],
21	with	IN	O	with	_	0	SENT_33	[p5l1374t274r1565b353],
22	environmental	JJ	O	environmental	amod	23	SENT_33	[p5l1600t275r2134b353, p5l21t401r132b479],
23	factors	NNS	O	factor	prep_with	20	SENT_33	[p5l176t401r471b479],
24	—	VBP	O	—	_	0	SENT_33	[p5l514t446r621b454],
25	inﬂuence	NN	O	inﬂuence	nn	26	SENT_33	[p5l661t401r1072b480],
26	sensitivity	NN	O	sensitivity	dobj	24	SENT_33	[p5l1118t402r1561b501],
27	to	TO	O	to	_	0	SENT_33	[p5l1602t418r1684b479],
28	warfarin	NN	O	warfarin	prep_to	24	SENT_33	[p5l1725t401r2130b480],
29	.	.	O	.	_	0	SENT_33	[p5l1725t401r2130b480],

1	Moreover	RB	O	moreover	advmod	8	SENT_34	[p5l18t536r440b623],
2	,	,	O	,	_	0	SENT_34	[p5l18t536r440b623],
3	a	DT	O	a	det	4	SENT_34	[p5l482t555r526b606],
4	number	NN	O	number	nsubj	8	SENT_34	[p5l562t528r898b607],
5	of	IN	O	of	_	0	SENT_34	[p5l932t528r1032b606],
6	efforts	NNS	O	effort	prep_of	4	SENT_34	[p5l1051t528r1333b606],
7	are	VBP	O	be	aux	8	SENT_34	[p5l1371t554r1499b606],
8	making	VBG	O	make	_	0	SENT_34	[p5l1536t528r1870b628],
9	sense	NN	O	sense	dobj	8	SENT_34	[p5l1905t554r2135b606],
10	of	IN	O	of	_	0	SENT_34	[p5l21t655r121b733],
11	emergent	JJ	O	emergent	amod	12	SENT_34	[p5l143t672r547b755],
12	findings	NNS	O	finding	prep_of	9	SENT_34	[p5l580t655r944b755],
13	in	IN	O	in	_	0	SENT_34	[p5l985t656r1067b732],
14	the	DT	O	the	det	15	SENT_34	[p5l1107t655r1239b733],
15	context	NN	O	context	prep_in	8	SENT_34	[p5l1279t672r1595b733],
16	of	IN	O	of	_	0	SENT_34	[p5l1630t655r1729b733],
17	potential	JJ	O	potential	amod	19	SENT_34	[p5l1748t655r2135b755],
18	clinical	JJ	O	clinical	amod	19	SENT_34	[p5l21t782r326b860],
19	applications	NNS	O	application	prep_of	15	SENT_34	[p5l360t782r891b882],
20	.	.	O	.	_	0	SENT_34	[p5l360t782r891b882],

1	One	CD	NUMBER	one	num	2	SENT_35	[p5l931t788r1100b860],
2	example	NN	O	example	nsubj	3	SENT_35	[p5l1135t782r1483b882],
3	involves	VBZ	O	involve	_	0	SENT_35	[p5l1517t782r1846b861],
4	activities	NNS	O	activity	dobj	3	SENT_35	[p5l1883t783r2134b861, p5l21t910r167b987],
5	of	IN	O	of	_	0	SENT_35	[p5l211t909r311b987],
6	the	DT	O	the	det	9	SENT_35	[p5l334t909r467b987],
7	Pharmacogenetics	NNP	ORGANIZATION	Pharmacogenetics	nn	9	SENT_35	[p5l507t909r1292b1009],
8	Research	NNP	ORGANIZATION	Research	nn	9	SENT_35	[p5l1335t909r1725b992],
9	Network	NNP	ORGANIZATION	Network	prep_of	4	SENT_35	[p5l1764t909r2140b988],
10	(	CD	NUMBER	(	num	11	SENT_35	[p5l26t1042r383b1131],
11	PGRN	NNP	O	PGRN	dep	9	SENT_35	[p5l26t1042r383b1131],
12	)	CD	NUMBER	)	num	11	SENT_35	[p5l26t1042r383b1131],
13	,	,	O	,	_	0	SENT_35	[p5l26t1042r383b1131],
14	a	DT	O	a	det	15	SENT_35	[p5l422t1063r466b1114],
15	consortium	NN	O	consortium	conj_and	9	SENT_35	[p5l499t1037r994b1115],
16	of	IN	O	of	_	0	SENT_35	[p5l1030t1036r1129b1114],
17	scientists	NNS	O	scientist	prep_of	15	SENT_35	[p5l1146t1037r1541b1114],
18	who	WP	O	who	nsubjpass	20	SENT_35	[p5l1573t1036r1755b1115],
19	are	VBP	O	be	auxpass	20	SENT_35	[p5l1789t1062r1918b1114],
20	supported	VBN	O	support	rcmod	15	SENT_35	[p5l1954t1062r2134b1136, p5l20t1163r301b1263],
21	by	IN	O	by	_	0	SENT_35	[p5l346t1163r443b1263],
22	the	DT	O	the	det	24	SENT_35	[p5l482t1163r614b1241],
23	National	NNP	ORGANIZATION	National	nn	24	SENT_35	[p5l656t1163r1028b1242],
24	Institutes	NNPS	ORGANIZATION	Institutes	agent	20	SENT_35	[p5l1070t1164r1475b1242],
25	of	IN	ORGANIZATION	of	_	0	SENT_35	[p5l1522t1163r1621b1241],
26	Health	NNP	ORGANIZATION	Health	prep_of	24	SENT_35	[p5l1645t1163r1935b1241],
27	and	CC	O	and	_	0	SENT_35	[p5l1978t1163r2135b1241],
28	who	WP	O	who	nsubj	30	SENT_35	[p5l16t1290r199b1369],
29	are	VBP	O	be	aux	30	SENT_35	[p5l238t1316r367b1368],
30	studying	VBG	O	study	prep_of	4	SENT_35	[p5l406t1290r778b1390],
31	how	WRB	O	how	advmod	34	SENT_35	[p5l813t1290r996b1369],
32	genetic	JJ	O	genetic	amod	33	SENT_35	[p5l1031t1291r1338b1390],
33	variation	NN	O	variation	nsubj	34	SENT_35	[p5l1371t1291r1753b1369],
34	contributes	VBZ	O	contribute	ccomp	30	SENT_35	[p5l1792t1290r2134b1368, p5l21t1433r191b1496],
35	to	TO	O	to	_	0	SENT_35	[p5l236t1434r317b1495],
36	differences	NNS	O	difference	prep_to	34	SENT_35	[p5l361t1417r834b1495],
37	in	IN	O	in	_	0	SENT_35	[p5l878t1418r961b1494],
38	drug	NN	O	drug	nn	39	SENT_35	[p5l1004t1417r1207b1517],
39	response	NN	O	response	prep_in	36	SENT_35	[p5l1246t1443r1625b1517],
40	among	IN	O	among	_	0	SENT_35	[p5l1667t1443r1966b1517],
41	patients	NNS	O	patient	prep_among	34	SENT_35	[p5l2003t1443r2134b1517, p5l21t1545r288b1622],
42	.	.	O	.	_	0	SENT_35	[p5l2003t1443r2134b1517, p5l21t1545r288b1622],

1	The	DT	O	the	det	3	SENT_36	[p5l327t1544r490b1622],
2	collected	VBN	O	collect	amod	3	SENT_36	[p5l527t1544r915b1622],
3	information	NN	O	information	nsubjpass	14	SENT_36	[p5l951t1544r1483b1622],
4	about	IN	O	about	_	0	SENT_36	[p5l1519t1544r1767b1623],
5	specific	JJ	O	specific	amod	6	SENT_36	[p5l1800t1544r2136b1644],
6	proteins	NNS	O	protein	prep_about	3	SENT_36	[p5l20t1672r388b1771],
7	,	,	O	,	_	0	SENT_36	[p5l20t1672r388b1771],
8	genes	NNS	O	gene	prep_about	3	SENT_36	[p5l427t1697r687b1771],
9	,	,	O	,	_	0	SENT_36	[p5l427t1697r687b1771],
10	and	CC	O	and	_	0	SENT_36	[p5l726t1671r881b1749],
11	pathways	NNS	O	pathway	conj_and	6	SENT_36	[p5l913t1671r1303b1771],
12	is	VBZ	O	be	aux	14	SENT_36	[p5l1338t1672r1403b1749],
13	being	VBG	O	be	auxpass	14	SENT_36	[p5l1440t1671r1675b1771],
14	integrated	VBN	O	integrate	_	0	SENT_36	[p5l1706t1671r2135b1771],
15	into	IN	O	into	_	0	SENT_36	[p5l20t1799r192b1876],
16	the	DT	O	the	det	17	SENT_36	[p5l261t1798r395b1876],
17	Pharmacogenetics	NNPS	MISC	Pharmacogenetics	prep_into	14	SENT_36	[p5l462t1798r1263b1898],
18	and	CC	O	and	_	0	SENT_36	[p5l1332t1798r1491b1876],
19	Pharmacogenomics	NNPS	O	Pharmacogenomics	nn	23	SENT_36	[p5l1557t1798r2134b1898, p5l21t1926r335b2003],
20	Knowledge	NNP	O	Knowledge	nn	23	SENT_36	[p5l391t1925r878b2025],
21	Base	NNP	O	Base	nn	23	SENT_36	[p5l931t1932r1130b2003],
22	(	NN	O	(	nn	23	SENT_36	[p5l1189t1925r2133b2025],
23	www.nigms.nih.gov	NN	O	www.nigms.nih.gov	prep_into	14	SENT_36	[p5l1189t1925r2133b2025],
24	/	:	O	/	punct	25	SENT_36	[p5l1189t1925r2133b2025],
25	Initiatives/PGRN	NNP	O	Initiatives/PGRN	dep	17	SENT_36	[p5l20t2053r850b2143],
26	/	:	O	/	punct	25	SENT_36	[p5l20t2053r850b2143],
27	)	CD	NUMBER	)	tmod	14	SENT_36	[p5l20t2053r850b2143],
28	.	.	O	.	_	0	SENT_36	[p5l20t2053r850b2143],

1	Several	JJ	O	several	amod	3	SENT_37	[p5l904t2052r1208b2131],
2	PGRN	NN	O	pgrn	nn	3	SENT_37	[p5l1252t2058r1530b2135],
3	investigators	NNS	O	investigator	nsubj	5	SENT_37	[p5l1574t2053r2133b2152],
4	have	VBP	O	have	aux	5	SENT_37	[p5l21t2179r206b2258],
5	joined	VBN	O	join	_	0	SENT_37	[p5l227t2179r497b2279],
6	with	IN	O	with	_	0	SENT_37	[p5l526t2179r717b2258],
7	non	JJ	O	non	prep_with	5	SENT_37	[p5l751t2185r1213b2262],
8	.	.	O	.	_	0	SENT_37	[p5l751t2185r1213b2262],

1	—	NN	O	—	_	0	SENT_38	[p5l751t2185r1213b2262],
2	.	.	O	.	_	0	SENT_38	[p5l751t2185r1213b2262],

1	PGRN	NNP	ORGANIZATION	PGRN	nn	2	SENT_39	[p5l751t2185r1213b2262],
2	investigators	NNS	O	investigator	nsubj	4	SENT_39	[p5l1244t2180r1778b2279],
3	to	TO	O	to	aux	4	SENT_39	[p5l1814t2196r1894b2257],
4	form	VB	O	form	_	0	SENT_39	[p5l1929t2179r2135b2257],
5	the	DT	O	the	det	11	SENT_39	[p5l21t2306r156b2384],
6	International	NNP	ORGANIZATION	International	nn	11	SENT_39	[p5l204t2306r783b2384],
7	Warfarin	NNP	ORGANIZATION	Warfarin	nn	11	SENT_39	[p5l828t2306r1223b2384],
8	Pharmacogenomics	NNP	ORGANIZATION	Pharmacogenomics	nn	11	SENT_39	[p5l1271t2306r2133b2406],
9	Consortium	NNP	ORGANIZATION	Consortium	nn	11	SENT_39	[p5l21t2434r546b2512],
10	(	CD	NUMBER	(	num	11	SENT_39	[p5l582t2433r2130b2533],
11	www.pharmgkb.org/views/project	NN	O	www.pharmgkb.org/views/project	dobj	4	SENT_39	[p5l582t2433r2130b2533],
12	.	.	O	.	_	0	SENT_39	[p5l582t2433r2130b2533],

1	jsp	NN	O	jsp	_	0	SENT_40	[p5l7t2558r531b2661],
2	?	.	O	?	_	0	SENT_40	[p5l7t2558r531b2661],

1	pId	NN	O	pid	_	0	SENT_41	[p5l7t2558r531b2661],
2	=	JJ	O	=	amod	1	SENT_41	[p5l7t2558r531b2661],
3	56	CD	NUMBER	56	num	4	SENT_41	[p5l7t2558r531b2661],
4	)	NN	O	)	tmod	2	SENT_41	[p5l7t2558r531b2661],
5	,	,	O	,	_	0	SENT_41	[p5l7t2558r531b2661],
6	a	DT	O	a	det	7	SENT_41	[p5l578t2587r623b2639],
7	group	NN	O	group	appos	4	SENT_41	[p5l662t2586r914b2661],
8	of	IN	O	of	_	0	SENT_41	[p5l958t2560r1057b2639],
9	research	NN	O	research	nn	10	SENT_41	[p5l1081t2561r1442b2639],
10	centers	NNS	O	center	prep_of	1	SENT_41	[p5l1485t2577r1787b2639],
11	around	IN	O	around	dep	1	SENT_41	[p5l1830t2561r2135b2640],
12	the	DT	O	the	det	13	SENT_41	[p5l21t2688r154b2766],
13	world	NN	O	world	pobj	11	SENT_41	[p5l189t2688r434b2767],
14	that	WDT	O	that	nsubj	16	SENT_41	[p5l475t2688r646b2766],
15	are	VBP	O	be	aux	16	SENT_41	[p5l680t2714r809b2766],
16	sharing	VBG	O	share	rcmod	13	SENT_41	[p5l851t2688r1178b2788],
17	their	PRP$	O	they	poss	18	SENT_41	[p5l1215t2688r1418b2766],
18	clinical	JJ	O	clinical	dobj	16	SENT_41	[p5l1456t2688r1769b2766],
19	and	CC	O	and	_	0	SENT_41	[p5l1807t2688r1964b2766],
20	genetic	JJ	O	genetic	amod	21	SENT_41	[p5l2004t2715r2134b2788, p5l21t2816r226b2893],
21	data	NNS	O	datum	conj_and	18	SENT_41	[p5l260t2815r440b2893],
22	to	TO	O	to	aux	23	SENT_41	[p5l474t2831r554b2893],
23	develop	VB	O	develop	xcomp	16	SENT_41	[p5l591t2815r905b2915],
24	a	DT	O	a	det	26	SENT_41	[p5l942t2842r986b2893],
25	consensus	NN	O	consensus	nn	26	SENT_41	[p5l1021t2841r1450b2894],
26	model	NN	O	model	dobj	23	SENT_41	[p5l1488t2815r1750b2893],
27	for	IN	O	for	_	0	SENT_41	[p5l1785t2815r1905b2893],
28	drug	NN	O	drug	nn	29	SENT_41	[p5l1938t2815r2138b2915],
29	administration	NN	O	administration	prep_for	23	SENT_41	[p5l20t2943r678b3022],
30	that	WDT	O	that	nsubj	32	SENT_41	[p5l720t2943r895b3022],
31	is	VBZ	O	be	cop	32	SENT_41	[p5l930t2944r996b3022],
32	consistent	JJ	O	consistent	rcmod	29	SENT_41	[p5l1040t2944r1488b3022],
33	with	IN	O	with	_	0	SENT_41	[p5l1519t2943r1716b3022],
34	all	DT	O	all	det	35	SENT_41	[p5l1757t2943r1863b3022],
35	available	JJ	O	available	prep_with	32	SENT_41	[p5l1903t2943r2134b3022, p5l11t3071r179b3150],

1	data	NNS	O	datum	_	0	SENT_42	[p5l218t3071r420b3150],
2	.	.	O	.	_	0	SENT_42	[p5l218t3071r420b3150],

1	The	DT	O	the	det	5	SENT_43	[p5l460t3071r619b3150],
2	Collaborative	JJ	O	collaborative	amod	5	SENT_43	[p5l658t3071r1215b3150],
3	Cardiovascular	NNP	O	Cardiovascular	nn	5	SENT_43	[p5l1254t3071r1885b3150],
4	Drug	NNP	O	Drug	nn	5	SENT_43	[p5l1920t3078r2138b3172],
5	Safety	NNP	O	Safety	nsubj	34	SENT_43	[p5l14t3199r274b3300],
6	and	CC	O	and	_	0	SENT_43	[p5l306t3199r464b3278],
7	Biomarker	NNP	O	Biomarker	nn	9	SENT_43	[p5l498t3199r951b3279],
8	Research	NNP	O	Research	nn	9	SENT_43	[p5l983t3199r1376b3283],
9	Program	NNP	O	Program	conj_and	5	SENT_43	[p5l1410t3206r1810b3300],
10	,	,	O	,	_	0	SENT_43	[p5l1410t3206r1810b3300],
11	a	DT	O	a	det	12	SENT_43	[p5l1851t3226r1896b3278],
12	partnership	NN	O	partnership	appos	5	SENT_43	[p5l1930t3216r2133b3300, p5l12t3327r332b3428],
13	between	IN	O	between	_	0	SENT_43	[p5l382t3327r740b3407],
14	the	DT	O	the	det	16	SENT_43	[p5l787t3327r920b3406],
15	Critical	JJ	ORGANIZATION	critical	amod	16	SENT_43	[p5l968t3327r1283b3406],
16	Path	NN	ORGANIZATION	path	prep_between	12	SENT_43	[p5l1329t3327r1519b3406],
17	Institute	NNP	ORGANIZATION	Institute	dep	16	SENT_43	[p5l1565t3328r1929b3406],
18	and	CC	O	and	_	0	SENT_43	[p5l1976t3327r2134b3406],
19	the	DT	O	the	det	20	SENT_43	[p5l12t3455r147b3534],
20	University	NNP	ORGANIZATION	University	prep_between	12	SENT_43	[p5l184t3456r629b3556],
21	of	IN	ORGANIZATION	of	_	0	SENT_43	[p5l662t3455r763b3534],
22	Utah	NNP	ORGANIZATION	Utah	prep_of	20	SENT_43	[p5l782t3455r993b3534],
23	that	WDT	O	that	nsubjpass	25	SENT_43	[p5l1031t3455r1207b3534],
24	is	VBZ	O	be	auxpass	25	SENT_43	[p5l1238t3456r1305b3534],
25	funded	VBN	O	fund	rcmod	12	SENT_43	[p5l1344t3455r1653b3534],
26	by	IN	O	by	_	0	SENT_43	[p5l1691t3455r1789b3556],
27	a	DT	O	a	det	28	SENT_43	[p5l1821t3482r1866b3534],
28	grant	NN	O	grant	agent	25	SENT_43	[p5l1901t3472r2139b3556],
29	from	IN	O	from	_	0	SENT_43	[p5l12t3583r219b3662],
30	the	DT	O	the	det	31	SENT_43	[p5l253t3583r384b3662],
31	FDA	NNP	ORGANIZATION	FDA	prep_from	28	SENT_43	[p5l416t3590r620b3679],
32	,	,	O	,	_	0	SENT_43	[p5l416t3590r620b3679],
33	is	VBZ	O	be	aux	34	SENT_43	[p5l657t3584r722b3662],
34	evaluating	VBG	O	evaluate	_	0	SENT_43	[p5l759t3583r1195b3684],
35	genetic	JJ	O	genetic	amod	36	SENT_43	[p5l1226t3584r1528b3684],
36	tests	NNS	O	test	dobj	34	SENT_43	[p5l1561t3600r1750b3662],
37	for	IN	O	for	_	0	SENT_43	[p5l1786t3583r1907b3662],
38	their	PRP$	O	they	poss	39	SENT_43	[p5l1938t3583r2137b3662],
39	ability	NN	O	ability	prep_for	34	SENT_43	[p5l11t3711r282b3812],
40	to	TO	O	to	aux	41	SENT_43	[p5l320t3728r402b3790],
41	predict	VB	O	predict	infmod	39	SENT_43	[p5l443t3711r747b3812],
42	safer	JJR	O	safer	amod	46	SENT_43	[p5l786t3711r994b3790],
43	and	CC	O	and	_	0	SENT_43	[p5l1032t3711r1190b3790],
44	more	RBR	O	more	advmod	45	SENT_43	[p5l1232t3737r1451b3790],
45	effective	JJ	O	effective	amod	46	SENT_43	[p5l1494t3711r1852b3790],
46	doses	NNS	O	dose	dobj	41	SENT_43	[p5l1895t3711r2132b3790],
47	of	IN	O	of	_	0	SENT_43	[p6l12t23r113b102],
48	warfarin	NN	O	warfarin	prep_of	46	SENT_43	[p6l128t23r526b103],
49	.	.	O	.	_	0	SENT_43	[p6l128t23r526b103],

1	Other	JJ	O	other	amod	2	SENT_44	[p6l569t23r817b102],
2	researchers	NNS	O	researcher	_	0	SENT_44	[p6l853t23r1341b102],
3	who	WP	O	who	nsubj	5	SENT_44	[p6l1377t23r1560b103],
4	are	VBP	O	be	aux	5	SENT_44	[p6l1599t49r1728b102],
5	conducting	VBG	O	conduct	rcmod	2	SENT_44	[p6l1767t23r2133b102, p6l11t152r149b252],

1	ancillary	JJ	O	ancillary	amod	3	SENT_45	[p6l186t151r556b252],
2	pharmacogenomic	JJ	O	pharmacogenomic	amod	3	SENT_45	[p6l591t151r1386b252],
3	studies	NNS	O	study	nsubj	26	SENT_45	[p6l1428t151r1722b230],
4	in	IN	O	in	_	0	SENT_45	[p6l1765t152r1847b229],
5	ongoing	JJ	O	ongoing	prep_in	3	SENT_45	[p6l1889t177r2133b252, p6l11t280r150b380],
6	or	CC	O	or	_	0	SENT_45	[p6l190t305r279b358],
7	completed	VBN	O	complete	amod	10	SENT_45	[p6l320t279r765b380],
8	clinical	JJ	O	clinical	amod	10	SENT_45	[p6l808t279r1122b358],
9	research	NN	O	research	nn	10	SENT_45	[p6l1164t279r1527b358],
10	projects	NNS	O	project	prep_in	3	SENT_45	[p6l1568t280r1906b380],
11	supported	VBN	O	support	partmod	10	SENT_45	[p6l1952t305r2133b380, p6l11t407r294b508],
12	by	IN	O	by	_	0	SENT_45	[p6l341t407r438b508],
13	the	DT	O	the	det	15	SENT_45	[p6l480t407r612b486],
14	National	NNP	O	National	nn	15	SENT_45	[p6l657t407r1030b486],
15	Heart	NNP	O	Heart	agent	11	SENT_45	[p6l1075t415r1342b503],
16	,	,	O	,	_	0	SENT_45	[p6l1075t415r1342b503],
17	Lung	NN	O	lung	agent	11	SENT_45	[p6l1392t415r1631b508],
18	,	,	O	,	_	0	SENT_45	[p6l1392t415r1631b508],
19	and	CC	O	and	_	0	SENT_45	[p6l1682t407r1840b486],
20	Blood	NNP	ORGANIZATION	Blood	nn	21	SENT_45	[p6l1885t407r2134b486],
21	Institute	NNP	ORGANIZATION	Institute	agent	11	SENT_45	[p6l11t536r383b614],
22	(	CD	NUMBER	(	num	23	SENT_45	[p6l440t542r807b627],
23	NHLBI	NNP	ORGANIZATION	NHLBI	dep	21	SENT_45	[p6l440t542r807b627],
24	)	CD	NUMBER	)	num	23	SENT_45	[p6l440t542r807b627],
25	have	VBP	O	have	aux	26	SENT_45	[p6l865t535r1057b614],
26	developed	VBN	O	develop	_	0	SENT_45	[p6l1111t535r1546b636],
27	a	DT	O	a	det	30	SENT_45	[p6l1597t562r1642b614],
28	free	JJ	O	free	amod	30	SENT_45	[p6l1693t535r1858b614],
29	Web	NN	O	web	nn	30	SENT_45	[p6l1907t535r2132b614],
30	—	NN	O	—	dobj	26	SENT_45	[p6l1907t535r2132b614],
31	based	VBN	O	base	partmod	30	SENT_45	[p6l12t663r261b742],
32	tool	NN	O	tool	dobj	31	SENT_45	[p6l306t663r472b742],
33	for	IN	O	for	_	0	SENT_45	[p6l514t663r638b742],
34	health	NN	O	health	nn	36	SENT_45	[p6l678t663r948b742],
35	care	NN	O	care	nn	36	SENT_45	[p6l992t690r1167b742],
36	professionals	NNS	O	professional	prep_for	31	SENT_45	[p6l1209t663r1781b764],
37	to	TO	O	to	aux	38	SENT_45	[p6l1827t680r1908b742],
38	estimate	VB	O	estimate	xcomp	31	SENT_45	[p6l1953t664r2133b742, p6l12t808r225b870],
39	the	DT	O	the	det	41	SENT_45	[p6l274t791r409b870],
40	beginning	NN	O	beginning	nn	41	SENT_45	[p6l458t791r914b892],
41	dose	NN	O	dose	dobj	38	SENT_45	[p6l959t791r1156b870],
42	for	IN	O	for	_	0	SENT_45	[p6l1205t791r1330b870],
43	patients	NNS	O	patient	prep_for	38	SENT_45	[p6l1374t792r1723b892],
44	who	WP	O	who	nsubj	46	SENT_45	[p6l1769t791r1954b870],
45	are	VBP	O	be	aux	46	SENT_45	[p6l2003t817r2134b870],
46	starting	VBG	O	start	rcmod	43	SENT_45	[p6l13t920r356b1020],
47	warfarin	NN	O	warfarin	nn	48	SENT_45	[p6l389t919r763b999],
48	therapy	NN	O	therapy	dobj	46	SENT_45	[p6l804t919r1126b1020],
49	(	CD	NUMBER	(	num	50	SENT_45	[p6l1167t919r2128b1020],
50	www	NN	O	www	dep	48	SENT_45	[p6l1167t919r2128b1020],
51	.	.	O	.	_	0	SENT_45	[p6l1167t919r2128b1020],

1	warfarindosing	NN	O	warfarindosing	_	0	SENT_46	[p6l1167t919r2128b1020],
2	.	.	O	.	_	0	SENT_46	[p6l1167t919r2128b1020],

1	org	NN	O	org	nsubj	12	SENT_47	[p6l12t1054r242b1148],
2	)	CD	NUMBER	)	num	1	SENT_47	[p6l12t1054r242b1148],
3	.7	CD	NUMBER	.7	dep	1	SENT_47	[p6l12t1054r242b1148],
4	And	CC	O	and	cc	3	SENT_47	[p6l274t1047r473b1143],
5	,	,	O	,	_	0	SENT_47	[p6l274t1047r473b1143],
6	most	RBS	O	most	advmod	7	SENT_47	[p6l514t1064r727b1126],
7	recently	RB	DATE	recently	advmod	12	SENT_47	[p6l757t1047r1102b1148],
8	,	,	O	,	_	0	SENT_47	[p6l757t1047r1102b1148],
9	the	DT	O	the	det	10	SENT_47	[p6l1143t1047r1274b1126],
10	NHLBI	NNP	ORGANIZATION	NHLBI	nsubj	12	SENT_47	[p6l1307t1054r1604b1126],
11	is	VBZ	O	be	aux	12	SENT_47	[p6l1637t1048r1702b1126],
12	awarding	VBG	O	award	_	0	SENT_47	[p6l1739t1047r2138b1148],
13	contracts	NNS	O	contract	dobj	12	SENT_47	[p6l12t1192r397b1254],
14	to	TO	O	to	aux	15	SENT_47	[p6l436t1192r517b1254],
15	conduct	VB	O	conduct	xcomp	12	SENT_47	[p6l555t1175r891b1254],
16	a	DT	O	a	det	21	SENT_47	[p6l921t1202r966b1254],
17	large	JJ	O	large	amod	21	SENT_47	[p6l1000t1175r1231b1276],
18	,	,	O	,	_	0	SENT_47	[p6l1000t1175r1231b1276],
19	multicenter	JJ	O	multicenter	amod	21	SENT_47	[p6l1273t1175r1777b1271],
20	,	,	O	,	_	0	SENT_47	[p6l1273t1175r1777b1271],
21	doubleblind	NN	O	doubleblind	dobj	15	SENT_47	[p6l1819t1175r2133b1254, p6l12t1303r257b1399],
22	,	,	O	,	_	0	SENT_47	[p6l1819t1175r2133b1254, p6l12t1303r257b1399],
23	randomized	VBN	O	randomize	partmod	21	SENT_47	[p6l310t1303r830b1382],
24	trial	NN	O	trial	nsubj	28	SENT_47	[p6l877t1303r1056b1382],
25	of	IN	O	of	_	0	SENT_47	[p6l1102t1303r1202b1382],
26	genotype	NN	O	genotype	nn	27	SENT_47	[p6l1230t1303r1958b1404],
27	—	NN	O	—	prep_of	24	SENT_47	[p6l1230t1303r1958b1404],
28	guided	VBD	O	guide	ccomp	23	SENT_47	[p6l1230t1303r1958b1404],
29	administration	NN	O	administration	dobj	28	SENT_47	[p6l2004t1303r2133b1382, p6l12t1432r554b1510],
30	of	IN	O	of	_	0	SENT_47	[p6l592t1431r692b1510],
31	warfarin	NN	O	warfarin	nn	32	SENT_47	[p6l707t1431r1082b1510],
32	therapy	NN	O	therapy	prep_of	29	SENT_47	[p6l1120t1431r1498b1532],
33	.8	CD	NUMBER	.8	num	32	SENT_47	[p6l1120t1431r1498b1532],

1	We	PRP	O	we	nsubj	6	SENT_48	[p6l137t1567r271b1638],
2	are	VBP	O	be	cop	6	SENT_48	[p6l311t1585r442b1638],
3	still	RB	O	still	advmod	6	SENT_48	[p6l484t1559r650b1638],
4	a	DT	O	a	det	6	SENT_48	[p6l689t1586r734b1638],
5	long	JJ	O	long	amod	6	SENT_48	[p6l772t1559r966b1660],
6	way	NN	O	way	_	0	SENT_48	[p6l999t1586r1168b1660],
7	from	IN	O	from	_	0	SENT_48	[p6l1204t1559r1418b1638],
8	the	DT	DATE	the	det	9	SENT_48	[p6l1459t1559r1594b1638],
9	day	NN	DATE	day	prep_from	6	SENT_48	[p6l1635t1559r1783b1660],
10	when	WRB	O	when	advmod	13	SENT_48	[p6l1815t1559r2052b1638],
11	a	DT	O	a	det	12	SENT_48	[p6l2091t1586r2136b1638],
12	patient	NN	O	patient	nsubj	43	SENT_48	[p6l11t1688r315b1788],
13	presents	VBZ	O	present	dep	9	SENT_48	[p6l356t1704r715b1788],
14	a	DT	O	a	det	17	SENT_48	[p6l765t1714r809b1766],
15	DNA	NN	O	dna	nn	17	SENT_48	[p6l854t1694r1063b1766],
16	“	NN	O	“	nn	17	SENT_48	[p6l1112t1687r1396b1788],
17	chip	NN	O	chip	nsubj	26	SENT_48	[p6l1112t1687r1396b1788],
18	,	,	O	,	_	0	SENT_48	[p6l1112t1687r1396b1788],
19	”	CD	NUMBER	”	appos	17	SENT_48	[p6l1112t1687r1396b1788],
20	a	DT	O	a	dep	21	SENT_48	[p6l1448t1714r1492b1766],
21	l	NN	O	l	amod	19	SENT_48	[p6l1538t1687r1954b1788],
22	<	JJR	O	<	dep	21	SENT_48	[p6l1538t1687r1954b1788],
23	ey	CD	NUMBER	ey	num	26	SENT_48	[p6l1538t1687r1954b1788],
24	—	NN	O	—	nn	26	SENT_48	[p6l1538t1687r1954b1788],
25	chain	NN	O	chain	nn	26	SENT_48	[p6l1538t1687r1954b1788],
26	tag	NN	O	tag	xcomp	13	SENT_48	[p6l2002t1704r2138b1788],
27	bearing	VBG	O	bear	partmod	26	SENT_48	[p6l12t1815r351b1916],
28	the	DT	O	the	det	29	SENT_48	[p6l401t1815r536b1894],
29	patient	NN	O	patient	poss	33	SENT_48	[p6l587t1816r959b1916],
30	’s	POS	O	’s	_	0	SENT_48	[p6l587t1816r959b1916],
31	electronic	JJ	O	electronic	amod	33	SENT_48	[p6l1015t1815r1445b1894],
32	health	NN	O	health	nn	33	SENT_48	[p6l1498t1815r1773b1894],
33	record	NN	O	record	dobj	27	SENT_48	[p6l1826t1815r2129b1911],
34	,	,	O	,	_	0	SENT_48	[p6l1826t1815r2129b1911],
35	and	CC	O	and	_	0	SENT_48	[p6l11t1943r171b2022],
36	an	DT	O	a	det	38	SENT_48	[p6l216t1969r320b2022],
37	insurance	NN	O	insurance	nn	38	SENT_48	[p6l365t1944r795b2022],
38	card	NN	O	card	dobj	27	SENT_48	[p6l841t1943r1029b2022],
39	to	TO	O	to	_	0	SENT_48	[p6l1075t1960r1158b2022],
40	a	DT	O	a	det	41	SENT_48	[p6l1204t1970r1248b2022],
41	physician	NN	O	physician	prep_to	38	SENT_48	[p6l1291t1943r1706b2044],
42	and	CC	O	and	_	0	SENT_48	[p6l1751t1943r1911b2022],
43	gets	VBZ	O	get	conj_and	13	SENT_48	[p6l1956t1960r2131b2044],
44	a	DT	O	a	det	45	SENT_48	[p6l11t2098r56b2150],
45	dose	NN	O	dose	dobj	43	SENT_48	[p6l101t2071r299b2150],
46	of	IN	O	of	_	0	SENT_48	[p6l346t2071r447b2150],
47	personalized	JJ	O	personalized	amod	48	SENT_48	[p6l473t2071r1043b2172],
48	medicine	NN	O	medicine	prep_of	45	SENT_48	[p6l1089t2071r1512b2150],
49	.	.	O	.	_	0	SENT_48	[p6l1089t2071r1512b2150],

1	Considerable	JJ	O	considerable	amod	2	SENT_49	[p6l1564t2071r2134b2150],
2	basic	JJ	O	basic	nsubj	6	SENT_49	[p6l12t2198r227b2276],
3	and	CC	O	and	_	0	SENT_49	[p6l262t2198r420b2276],
4	clinical	JJ	O	clinical	amod	5	SENT_49	[p6l458t2198r772b2276],
5	research	NN	O	research	conj_and	2	SENT_49	[p6l808t2198r1171b2276],
6	needs	VBZ	O	need	_	0	SENT_49	[p6l1208t2198r1451b2276],
7	to	TO	O	to	aux	9	SENT_49	[p6l1490t2215r1572b2276],
8	be	VB	O	be	auxpass	9	SENT_49	[p6l1611t2198r1707b2276],
9	done	VBN	O	do	xcomp	6	SENT_49	[p6l1746t2198r1975b2293],
10	,	,	O	,	_	0	SENT_49	[p6l1746t2198r1975b2293],
11	including	VBG	O	include	_	0	SENT_49	[p6l2018t2199r2133b2275, p6l12t2326r342b2427],
12	investigations	NNS	O	investigation	prep_including	9	SENT_49	[p6l381t2327r991b2427],
13	of	IN	O	of	_	0	SENT_49	[p6l1037t2326r1138b2405],
14	gene	NN	O	gene	nn	16	SENT_49	[p6l1161t2352r1631b2427],
15	—	NN	O	—	nn	16	SENT_49	[p6l1161t2352r1631b2427],
16	gene	NN	O	gene	prep_of	12	SENT_49	[p6l1161t2352r1631b2427],
17	and	CC	O	and	_	0	SENT_49	[p6l1673t2326r1832b2405],
18	geneenvironment	NN	O	geneenvironment	nn	19	SENT_49	[p6l1875t2352r2137b2427, p6l12t2456r571b2534],
19	interactions	NNS	O	interaction	prep_of	12	SENT_49	[p6l599t2456r1134b2534],
20	.	.	O	.	_	0	SENT_49	[p6l599t2456r1134b2534],

1	Evidence	NN	O	evidence	nsubj	8	SENT_50	[p6l1172t2455r1547b2534],
2	from	IN	O	from	_	0	SENT_50	[p6l1582t2455r1792b2534],
3	various	JJ	O	various	amod	4	SENT_50	[p6l1822t2456r2132b2534],
4	clinical	JJ	O	clinical	prep_from	1	SENT_50	[p6l12t2583r318b2662],
5	and	CC	O	and	_	0	SENT_50	[p6l359t2583r514b2662],
6	population	NN	O	population	nn	7	SENT_50	[p6l554t2583r1016b2684],
7	studies	NNS	O	study	prep_from	1	SENT_50	[p6l1058t2583r1351b2662],
8	suggests	VBZ	O	suggest	_	0	SENT_50	[p6l1397t2600r1756b2684],
9	that	IN	O	that	complm	19	SENT_50	[p6l1800t2583r1969b2662],
10	patients	NNS	O	patient	nsubj	19	SENT_50	[p6l2004t2609r2133b2684, p6l12t2712r254b2790],
11	of	IN	O	of	_	0	SENT_50	[p6l293t2711r394b2790],
12	Asian	JJ	MISC	asian	amod	18	SENT_50	[p6l409t2712r682b2807],
13	,	,	O	,	_	0	SENT_50	[p6l409t2712r682b2807],
14	European	JJ	MISC	european	conj_and	12	SENT_50	[p6l723t2719r1167b2812],
15	,	,	O	,	_	0	SENT_50	[p6l723t2719r1167b2812],
16	and	CC	O	and	_	0	SENT_50	[p6l1209t2711r1368b2790],
17	African	NNP	MISC	African	conj_and	12	SENT_50	[p6l1401t2711r1732b2790],
18	ancestry	NN	O	ancestry	prep_of	10	SENT_50	[p6l1767t2728r2138b2812],
19	require	VB	O	require	ccomp	8	SENT_50	[p6l12t2840r348b2940],
20	,	,	O	,	_	0	SENT_50	[p6l12t2840r348b2940],
21	on	IN	O	on	_	0	SENT_50	[p6l416t2865r522b2918],
22	average	NN	O	average	prep_on	19	SENT_50	[p6l582t2865r931b2940],
23	,	,	O	,	_	0	SENT_50	[p6l582t2865r931b2940],
24	lower	JJR	O	lower	amod	30	SENT_50	[p6l996t2839r1257b2935],
25	,	,	O	,	_	0	SENT_50	[p6l996t2839r1257b2935],
26	intermediate	JJ	O	intermediate	conj_and	24	SENT_50	[p6l1323t2839r1908b2935],
27	,	,	O	,	_	0	SENT_50	[p6l1323t2839r1908b2935],
28	and	CC	O	and	_	0	SENT_50	[p6l1974t2839r2134b2918],
29	higher	JJR	O	higher	conj_and	24	SENT_50	[p6l12t2967r296b3068],
30	doses	NNS	O	dose	dobj	19	SENT_50	[p6l334t2967r566b3046],
31	of	IN	O	of	_	0	SENT_50	[p6l608t2967r707b3046],
32	warfarin	NN	O	warfarin	prep_of	30	SENT_50	[p6l724t2967r1113b3063],
33	,	,	O	,	_	0	SENT_50	[p6l724t2967r1113b3063],
34	respectively	RB	O	respectively	advmod	32	SENT_50	[p6l1157t2967r1664b3068],
35	;	:	O	;	_	0	SENT_50	[p6l1157t2967r1664b3068],
36	additional	JJ	O	additional	amod	37	SENT_50	[p6l1707t2967r2134b3046],
37	studies	NNS	O	study	nsubjpass	49	SENT_50	[p6l13t3095r313b3174],
38	involving	VBG	O	involve	_	0	SENT_50	[p6l363t3095r760b3196],
39	larger	JJR	O	larger	amod	40	SENT_50	[p6l804t3095r1058b3196],
40	numbers	NNS	O	number	prep_involving	37	SENT_50	[p6l1104t3095r1481b3174],
41	of	IN	O	of	_	0	SENT_50	[p6l1532t3095r1632b3174],
42	patients	NNS	O	patient	prep_of	40	SENT_50	[p6l1660t3096r2002b3196],
43	of	IN	O	of	_	0	SENT_50	[p6l2053t3095r2152b3174],
44	African	JJ	MISC	african	amod	47	SENT_50	[p6l8t3224r326b3303],
45	and	CC	O	and	_	0	SENT_50	[p6l361t3224r517b3303],
46	Asian	JJ	MISC	asian	amod	47	SENT_50	[p6l549t3225r789b3303],
47	descent	NN	O	descent	prep_of	42	SENT_50	[p6l825t3224r1143b3303],
48	are	VBP	O	be	auxpass	49	SENT_50	[p6l1173t3250r1300b3303],
49	needed	VBN	O	need	parataxis	8	SENT_50	[p6l1336t3224r1634b3303],
50	to	TO	O	to	aux	51	SENT_50	[p6l1671t3241r1751b3303],
51	confirm	VB	O	confirm	xcomp	49	SENT_50	[p6l1788t3224r2134b3303],
52	these	DT	O	these	det	53	SENT_50	[p6l12t3353r236b3432],
53	associations	NNS	O	association	dobj	51	SENT_50	[p6l274t3354r863b3432],
54	.9	IN	NUMBER	.9	prep	51	SENT_50	[p6l274t3354r863b3432],

1	After	IN	O	after	mark	11	SENT_51	[p6l137t3481r364b3560],
2	strong	JJ	O	strong	amod	3	SENT_51	[p6l409t3498r692b3582],
3	associations	NNS	O	association	nsubjpass	11	SENT_51	[p6l735t3482r1273b3560],
4	between	IN	O	between	_	0	SENT_51	[p6l1322t3481r1686b3561],
5	genotype	NN	O	genotype	nn	8	SENT_51	[p6l1732t3498r2134b3582],
6	and	CC	O	and	_	0	SENT_51	[p6l11t3609r171b3688],
7	drug	NN	O	drug	nn	8	SENT_51	[p6l218t3609r421b3710],
8	sensitivity	NN	O	sensitivity	prep_between	3	SENT_51	[p6l465t3610r898b3710],
9	have	VBP	O	have	aux	11	SENT_51	[p6l938t3609r1128b3688],
10	been	VBN	O	be	auxpass	11	SENT_51	[p6l1174t3609r1376b3688],
11	identified	VBN	O	identify	advcl	16	SENT_51	[p6l1420t3609r1861b3705],
12	,	,	O	,	_	0	SENT_51	[p6l1420t3609r1861b3705],
13	trials	NNS	O	trial	nsubjpass	16	SENT_51	[p6l1912t3609r2131b3688],
14	must	MD	O	must	aux	16	SENT_51	[p7l12t37r228b99],
15	be	VB	O	be	auxpass	16	SENT_51	[p7l268t20r364b99],
16	conducted	VBN	O	conduct	_	0	SENT_51	[p7l411t20r852b99],
17	to	TO	O	to	aux	18	SENT_51	[p7l897t37r978b99],
18	evaluate	VB	O	evaluate	ccomp	16	SENT_51	[p7l1026t20r1371b100],
19	the	DT	O	the	det	21	SENT_51	[p7l1417t20r1549b99],
20	clinical	JJ	O	clinical	amod	21	SENT_51	[p7l1595t20r1908b99],
21	efficacy	NN	O	efficacy	dobj	18	SENT_51	[p7l1954t20r2133b99, p7l12t175r197b249],
22	of	IN	O	of	_	0	SENT_51	[p7l235t148r335b227],
23	the	DT	O	the	det	25	SENT_51	[p7l360t148r493b227],
24	gene	NN	O	gene	nn	25	SENT_51	[p7l536t148r1019b249],
25	—	NN	O	—	prep_of	21	SENT_51	[p7l536t148r1019b249],
26	based	VBN	O	base	partmod	25	SENT_51	[p7l536t148r1019b249],
27	prescribing	VBG	O	prescribe	xcomp	26	SENT_51	[p7l1061t148r1553b249],
28	strategy	NN	O	strategy	dobj	27	SENT_51	[p7l1595t165r1938b249],
29	and	CC	O	and	_	0	SENT_51	[p7l1976t148r2134b227],
30	to	TO	O	to	aux	31	SENT_51	[p7l12t293r95b355],
31	determine	VB	O	determine	conj_and	18	SENT_51	[p7l136t276r582b355],
32	whether	IN	O	whether	_	0	SENT_51	[p7l618t276r980b355],
33	the	DT	O	the	det	34	SENT_51	[p7l1016t276r1151b355],
34	increment	NN	O	increment	prep_whether	31	SENT_51	[p7l1190t277r1637b355],
35	in	IN	O	in	_	0	SENT_51	[p7l1671t277r1755b354],
36	efficacy	NN	O	efficacy	nn	39	SENT_51	[p7l1795t276r2138b377],
37	or	CC	O	or	_	0	SENT_51	[p7l12t430r102b483],
38	safety	NN	O	safety	nn	39	SENT_51	[p7l151t404r409b505],
39	warrants	NNS	O	warrant	prep_in	34	SENT_51	[p7l451t421r842b484],
40	the	DT	O	the	det	41	SENT_51	[p7l895t404r1030b483],
41	cost	NN	O	cost	dobj	31	SENT_51	[p7l1081t421r1260b483],
42	of	IN	O	of	_	0	SENT_51	[p7l1306t404r1407b483],
43	genetic	JJ	O	genetic	amod	44	SENT_51	[p7l1439t405r1754b505],
44	testing	NN	O	testing	prep_of	41	SENT_51	[p7l1805t405r2129b505],
45	.	.	O	.	_	0	SENT_51	[p7l1805t405r2129b505],

1	Moreover	RB	O	moreover	advmod	10	SENT_52	[p7l9t540r433b628],
2	,	,	O	,	_	0	SENT_52	[p7l9t540r433b628],
3	genetic	JJ	O	genetic	amod	4	SENT_52	[p7l480t533r789b633],
4	stratification	NN	O	stratification	nsubjpass	10	SENT_52	[p7l831t532r1391b611],
5	in	IN	O	in	_	0	SENT_52	[p7l1432t533r1515b610],
6	clinical	JJ	O	clinical	amod	7	SENT_52	[p7l1558t532r1871b611],
7	trials	NNS	O	trial	prep_in	4	SENT_52	[p7l1912t532r2132b611],
8	will	MD	O	will	aux	10	SENT_52	[p7l7t660r172b739],
9	be	VB	O	be	auxpass	10	SENT_52	[p7l229t660r326b739],
10	needed	VBN	O	need	_	0	SENT_52	[p7l382t660r686b739],
11	to	TO	O	to	aux	12	SENT_52	[p7l743t677r825b739],
12	evaluate	VB	O	evaluate	xcomp	10	SENT_52	[p7l884t660r1229b740],
13	new	JJ	O	new	amod	15	SENT_52	[p7l1286t686r1463b739],
14	drugs	NNS	O	drug	nn	15	SENT_52	[p7l1517t660r1761b761],
15	—	NN	O	—	dobj	12	SENT_52	[p7l1816t705r1924b713],
16	and	CC	O	and	_	0	SENT_52	[p7l1976t660r2134b739],
17	indeed	RB	O	indeed	advmod	23	SENT_52	[p7l11t788r316b884],
18	,	,	O	,	_	0	SENT_52	[p7l11t788r316b884],
19	genetic	JJ	O	genetic	amod	20	SENT_52	[p7l355t789r657b889],
20	information	NN	O	information	nsubj	23	SENT_52	[p7l690t788r1203b867],
21	will	MD	O	will	aux	23	SENT_52	[p7l1232t788r1394b867],
22	be	VB	O	be	cop	23	SENT_52	[p7l1428t788r1523b867],
23	invaluable	JJ	O	invaluable	conj_and	10	SENT_52	[p7l1556t788r1982b867],
24	for	IN	O	for	_	0	SENT_52	[p7l2016t788r2137b867],
25	the	DT	O	the	det	26	SENT_52	[p7l12t916r145b995],
26	design	NN	O	design	prep_for	23	SENT_52	[p7l182t916r464b1017],
27	of	IN	O	of	_	0	SENT_52	[p7l501t916r601b995],
28	new	JJ	O	new	amod	29	SENT_52	[p7l619t942r797b995],
29	agents	NNS	O	agent	prep_of	26	SENT_52	[p7l829t933r1105b1017],
30	to	TO	O	to	aux	31	SENT_52	[p7l1143t933r1225b995],
31	serve	VB	O	serve	xcomp	23	SENT_52	[p7l1264t942r1479b995],
32	as	IN	O	as	_	0	SENT_52	[p7l1515t943r1600b995],
33	alternatives	NNS	O	alternative	prep_as	31	SENT_52	[p7l1638t916r2132b995],
34	to	TO	O	to	_	0	SENT_52	[p7l12t1061r94b1123],
35	existing	VBG	O	exist	amod	36	SENT_52	[p7l142t1045r486b1145],
36	drugs	NNS	O	drug	prep_to	23	SENT_52	[p7l530t1044r773b1145],
37	that	WDT	O	that	nsubj	39	SENT_52	[p7l822t1044r995b1123],
38	are	VBP	O	be	cop	39	SENT_52	[p7l1036t1070r1164b1123],
39	likely	JJ	O	likely	rcmod	36	SENT_52	[p7l1210t1044r1443b1145],
40	to	TO	O	to	aux	41	SENT_52	[p7l1485t1061r1566b1123],
41	produce	VB	O	produce	xcomp	39	SENT_52	[p7l1613t1044r1958b1145],
42	adverse	JJ	O	adverse	amod	43	SENT_52	[p7l2004t1044r2133b1123, p7l7t1199r224b1251],
43	effects	NNS	O	effect	dobj	41	SENT_52	[p7l262t1172r544b1251],
44	in	IN	O	in	_	0	SENT_52	[p7l583t1173r666b1250],
45	genetically	RB	O	genetically	advmod	46	SENT_52	[p7l704t1172r1171b1273],
46	susceptible	JJ	O	susceptible	amod	47	SENT_52	[p7l1205t1172r1680b1273],
47	patients	NNS	O	patient	prep_in	41	SENT_52	[p7l1717t1173r2084b1273],
48	.	.	O	.	_	0	SENT_52	[p7l1717t1173r2084b1273],

1	The	DT	O	the	det	2	SENT_53	[p7l137t1300r299b1379],
2	merits	NNS	O	merit	nsubj	10	SENT_53	[p7l346t1301r616b1379],
3	of	IN	O	of	_	0	SENT_53	[p7l666t1300r766b1379],
4	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	2	SENT_53	[p7l793t1300r1645b1401],
5	will	MD	O	will	aux	10	SENT_53	[p7l1690t1300r1854b1379],
6	probably	RB	O	probably	advmod	10	SENT_53	[p7l1899t1300r2133b1401, p7l11t1428r185b1529],
7	be	VB	O	be	cop	10	SENT_53	[p7l220t1428r317b1507],
8	an	DT	O	a	det	10	SENT_53	[p7l355t1454r458b1507],
9	active	JJ	O	active	amod	10	SENT_53	[p7l497t1429r737b1507],
10	area	NN	O	area	_	0	SENT_53	[p7l776t1454r956b1507],
11	of	IN	O	of	_	0	SENT_53	[p7l995t1428r1094b1507],
12	research	NN	O	research	prep_of	10	SENT_53	[p7l1115t1428r1477b1507],
13	for	IN	O	for	_	0	SENT_53	[p7l1516t1428r1640b1507],
14	some	DT	O	some	det	15	SENT_53	[p7l1677t1454r1901b1507],
15	time	NN	O	time	prep_for	12	SENT_53	[p7l1941t1429r2134b1507],
16	to	TO	O	to	aux	17	SENT_53	[p7l12t1573r95b1635],
17	come	VB	O	come	infmod	15	SENT_53	[p7l142t1582r397b1635],
18	.	.	O	.	_	0	SENT_53	[p7l142t1582r397b1635],

1	However	RB	O	however	advmod	21	SENT_54	[p7l448t1564r849b1652],
2	,	,	O	,	_	0	SENT_54	[p7l448t1564r849b1652],
3	the	DT	O	the	det	4	SENT_54	[p7l901t1556r1035b1635],
4	study	NN	O	study	nsubj	21	SENT_54	[p7l1083t1556r1317b1657],
5	by	IN	O	by	_	0	SENT_54	[p7l1359t1556r1457b1657],
6	Schwarz	NNP	PERSON	Schwarz	prep_by	4	SENT_54	[p7l1500t1556r1864b1635],
7	et	FW	O	et	nn	8	SENT_54	[p7l1911t1573r1989b1635],
8	al.	FW	O	al.	dep	6	SENT_54	[p7l2029t1556r2128b1635],
9	of	IN	O	of	_	0	SENT_54	[p7l12t1684r113b1763],
10	the	DT	O	the	det	12	SENT_54	[p7l137t1684r270b1763],
11	relative	JJ	O	relative	amod	12	SENT_54	[p7l310t1684r619b1763],
12	role	NN	O	role	prep_of	8	SENT_54	[p7l659t1684r819b1763],
13	of	IN	O	of	_	0	SENT_54	[p7l859t1684r959b1763],
14	genetic	JJ	O	genetic	amod	15	SENT_54	[p7l981t1685r1289b1785],
15	variants	NNS	O	variant	prep_of	12	SENT_54	[p7l1324t1685r1667b1763],
16	in	IN	O	in	_	0	SENT_54	[p7l1708t1685r1792b1762],
17	the	DT	O	the	det	18	SENT_54	[p7l1832t1684r1965b1763],
18	administration	NN	O	administration	prep_in	15	SENT_54	[p7l2005t1684r2133b1763, p7l12t1813r566b1891],
19	of	IN	O	of	_	0	SENT_54	[p7l621t1812r722b1891],
20	warfarin	NN	O	warfarin	prep_of	18	SENT_54	[p7l752t1812r1135b1891],
21	confirms	VBZ	O	confirm	_	0	SENT_54	[p7l1190t1812r1591b1891],
22	the	DT	O	the	det	23	SENT_54	[p7l1647t1812r1782b1891],
23	importance	NN	O	importance	dobj	21	SENT_54	[p7l1836t1813r2133b1913, p7l12t1957r245b2019],
24	of	IN	O	of	_	0	SENT_54	[p7l297t1940r398b2019],
25	genetic	JJ	O	genetic	amod	26	SENT_54	[p7l431t1941r745b2041],
26	variation	NN	O	variation	prep_of	23	SENT_54	[p7l791t1941r1183b2019],
27	in	IN	O	in	_	0	SENT_54	[p7l1234t1941r1318b2018],
28	influencing	VBG	O	influence	prepc_in	21	SENT_54	[p7l1369t1940r1882b2041],
29	drug	NN	O	drug	nn	30	SENT_54	[p7l1930t1940r2138b2041],
30	metabolism	NN	O	metabolism	dobj	28	SENT_54	[p7l12t2068r522b2147],
31	and	CC	O	and	_	0	SENT_54	[p7l568t2068r726b2147],
32	response	NN	O	response	dobj	28	SENT_54	[p7l771t2094r1151b2169],
33	to	TO	O	to	_	0	SENT_54	[p7l1198t2085r1279b2147],
34	therapy	NN	O	therapy	prep_to	28	SENT_54	[p7l1327t2068r1662b2169],
35	.	.	O	.	_	0	SENT_54	[p7l1327t2068r1662b2169],

1	Ready	JJ	O	ready	_	0	SENT_55	[p7l1712t2068r1973b2169],
2	for	IN	O	for	prep	1	SENT_55	[p7l2014t2068r2137b2147],

1	1062	CD	DATE	1062	num	4	SENT_56	[p7l149t2244r225b2266],
2	N	NN	O	n	nn	4	SENT_56	[p7l917t2255r930b2270],
3	ENGLJ	NN	O	englj	nn	4	SENT_56	[p7l945t2255r1023b2277],
4	MED	NN	O	med	_	0	SENT_56	[p7l1038t2255r1090b2270],
5	358	CD	NUMBER	358	num	7	SENT_56	[p7l1100t2249r1177b2277],
6	;	:	O	;	_	0	SENT_56	[p7l1100t2249r1177b2277],
7	1o	CD	NUMBER	1o	dep	4	SENT_56	[p7l1100t2249r1177b2277],
8	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	9	SENT_56	[p7l1209t2255r1411b2277],
9	MARCH	NNP	DATE	MARCH	dep	4	SENT_56	[p7l1448t2255r1533b2271],
10	6	CD	DATE	6	num	9	SENT_56	[p7l1546t2249r1566b2275],
11	,	,	DATE	,	_	0	SENT_56	[p7l1546t2249r1566b2275],
12	2008	CD	DATE	2008	num	9	SENT_56	[p7l1578t2249r1641b2271],

1	EDITORIAL	NN	O	editorial	_	0	SENT_57	[p7l991t2476r1169b2495],

1	prime	JJ	O	prime	amod	2	SENT_58	[p7l7t2691r255b2789],
2	time	NN	O	time	_	0	SENT_58	[p7l290t2687r514b2767],
3	?	.	O	?	_	0	SENT_58	[p7l290t2687r514b2767],

1	Perhaps	RB	O	perhaps	advmod	22	SENT_59	[p7l548t2690r876b2789],
2	not	RB	O	not	ccomp	22	SENT_59	[p7l911t2706r1051b2767],
3	quite	RB	O	quite	advmod	4	SENT_59	[p7l1081t2691r1287b2789],
4	yet	RB	O	yet	dep	2	SENT_59	[p7l1318t2706r1459b2789],
5	,	,	O	,	_	0	SENT_59	[p7l1318t2706r1459b2789],
6	but	CC	O	but	_	0	SENT_59	[p7l1499t2690r1635b2768],
7	with	IN	O	with	ccomp	22	SENT_59	[p7l1660t2690r1850b2768],
8	genebased	JJ	O	genebased	amod	10	SENT_59	[p7l1884t2715r2111b2789, p7l10t2816r252b2894],
9	clinical	JJ	O	clinical	amod	10	SENT_59	[p7l309t2816r620b2894],
10	studies	NNS	O	study	pobj	7	SENT_59	[p7l678t2816r975b2895],
11	in	IN	O	in	_	0	SENT_59	[p7l1034t2817r1117b2893],
12	place	NN	O	place	prep_in	10	SENT_59	[p7l1173t2816r1391b2916],
13	or	CC	O	or	_	0	SENT_59	[p7l1448t2842r1537b2894],
14	planned	VBN	O	plan	conj_or	10	SENT_59	[p7l1589t2816r1936b2916],
15	for	IN	O	for	_	0	SENT_59	[p7l1993t2816r2116b2894],
16	the	DT	DATE	the	det	18	SENT_59	[p7l10t2943r141b3021],
17	near	JJ	DATE	near	amod	18	SENT_59	[p7l182t2969r371b3021],
18	future	NN	DATE	future	prep_for	14	SENT_59	[p7l409t2943r692b3038],
19	,	,	O	,	_	0	SENT_59	[p7l409t2943r692b3038],
20	we	PRP	O	we	nsubj	22	SENT_59	[p7l734t2970r850b3022],
21	can	MD	O	can	aux	22	SENT_59	[p7l892t2969r1040b3021],
22	expect	VB	O	expect	_	0	SENT_59	[p7l1082t2960r1356b3043],
23	to	TO	O	to	aux	24	SENT_59	[p7l1392t2960r1473b3021],
24	have	VB	O	have	xcomp	22	SENT_59	[p7l1516t2943r1703b3022],
25	a	DT	O	a	det	27	SENT_59	[p7l1744t2970r1788b3021],
26	clearer	JJR	O	clearer	amod	27	SENT_59	[p7l1828t2943r2115b3021],
27	understanding	NN	O	understanding	dobj	24	SENT_59	[p7l9t3070r639b3170],
28	of	IN	O	of	_	0	SENT_59	[p7l677t3070r776b3148],
29	the	DT	O	the	det	31	SENT_59	[p7l799t3070r930b3148],
30	relative	JJ	O	relative	amod	31	SENT_59	[p7l970t3070r1276b3149],
31	merits	NNS	O	merit	prep_of	27	SENT_59	[p7l1316t3071r1584b3148],
32	of	IN	O	of	_	0	SENT_59	[p7l1627t3070r1726b3148],
33	pharmacogenomics	NNS	O	pharmacogenomic	prep_of	31	SENT_59	[p7l1747t3070r2111b3170, p7l10t3198r515b3297],
34	in	IN	O	in	_	0	SENT_59	[p7l554t3198r637b3274],
35	everyday	JJ	O	everyday	amod	37	SENT_59	[p7l676t3197r1040b3297],
36	clinical	JJ	O	clinical	amod	37	SENT_59	[p7l1074t3197r1384b3275],
37	practice	NN	O	practice	prep_in	33	SENT_59	[p7l1420t3198r1778b3297],
38	.	.	O	.	_	0	SENT_59	[p7l1420t3198r1778b3297],

1	N	NN	O	n	nn	2	SENT_60	[p7l91t3349r147b3403],
2	o	NN	O	o	nn	4	SENT_60	[p7l151t3363r186b3403],
3	potential	JJ	O	potential	amod	4	SENT_60	[p7l213t3344r498b3418],
4	conﬂict	NN	O	conﬂict	nsubjpass	12	SENT_60	[p7l526t3344r770b3403],
5	of	IN	O	of	_	0	SENT_60	[p7l793t3344r869b3403],
6	interest	NN	O	interest	prep_of	4	SENT_60	[p7l882t3345r1125b3402],
7	relevant	JJ	O	relevant	amod	6	SENT_60	[p7l1149t3344r1404b3403],
8	to	TO	O	to	_	0	SENT_60	[p7l1426t3357r1487b3403],
9	this	DT	O	this	det	10	SENT_60	[p7l1515t3344r1630b3402],
10	article	NN	O	article	prep_to	7	SENT_60	[p7l1658t3344r1854b3402],
11	was	VBD	O	be	auxpass	12	SENT_60	[p7l1878t3363r1999b3403],
12	reported	VBN	O	report	_	0	SENT_60	[p7l2027t3363r2112b3402, p7l7t3428r234b3502],
13	.	.	O	.	_	0	SENT_60	[p7l2027t3363r2112b3402, p7l7t3428r234b3502],

1	From	IN	O	from	dep	13	SENT_61	[p7l14t3575r181b3629],
2	the	DT	O	the	det	4	SENT_61	[p7l213t3569r317b3629],
3	National	NNP	O	National	nn	4	SENT_61	[p7l351t3569r631b3629],
4	Heart	NNP	O	Heart	pobj	1	SENT_61	[p7l670t3575r870b3639],
5	,	,	O	,	_	0	SENT_61	[p7l670t3575r870b3639],
6	Lung	NN	O	lung	conj_and	4	SENT_61	[p7l909t3575r1086b3648],
7	,	,	O	,	_	0	SENT_61	[p7l909t3575r1086b3648],
8	and	CC	O	and	_	0	SENT_61	[p7l1120t3569r1236b3629],
9	Blood	NNP	ORGANIZATION	Blood	nn	10	SENT_61	[p7l1275t3569r1460b3629],
10	Institute	NNP	ORGANIZATION	Institute	conj_and	4	SENT_61	[p7l1498t3575r1792b3639],
11	,	,	O	,	_	0	SENT_61	[p7l1498t3575r1792b3639],
12	National	NNP	ORGANIZATION	National	nn	13	SENT_61	[p7l1830t3569r2110b3629],
13	Institutes	NNPS	ORGANIZATION	Institutes	_	0	SENT_61	[p7l14t3669r314b3723],
14	of	IN	ORGANIZATION	of	_	0	SENT_61	[p7l341t3663r412b3723],
15	Health	NNP	ORGANIZATION	Health	dep	19	SENT_61	[p7l429t3663r659b3733],
16	,	,	O	,	_	0	SENT_61	[p7l429t3663r659b3733],
17	Bethesda	NNP	LOCATION	Bethesda	dep	15	SENT_61	[p7l692t3663r1005b3733],
18	,	,	O	,	_	0	SENT_61	[p7l692t3663r1005b3733],
19	MD.	NNP	LOCATION	MD.	prep_of	13	SENT_61	[p7l1037t3669r1171b3723],
20	.	.	O	.	_	0	SENT_61	[p7l1037t3669r1171b3723],

1	1	LS	NUMBER	1	_	0	SENT_62	[p8l11t51r59b102],
2	.	.	O	.	_	0	SENT_62	[p8l11t51r59b102],

1	International	NNP	O	International	nn	3	SENT_63	[p8l135t44r567b102],
2	HapMap	NNP	O	HapMap	nn	3	SENT_63	[p8l589t49r864b118],
3	Consortium	NNP	O	Consortium	_	0	SENT_63	[p8l887t45r1296b103],
4	.	.	O	.	_	0	SENT_63	[p8l887t45r1296b103],

1	A	DT	DURATION	a	det	3	SENT_64	[p8l1320t49r1369b101],
2	second	JJ	DURATION	second	amod	3	SENT_64	[p8l1390t44r1615b102],
3	generation	NN	O	generation	_	0	SENT_64	[p8l1636t45r1987b119],
4	human	JJ	O	human	amod	6	SENT_64	[p8l2008t44r2112b103, p8l8t158r152b197],
5	haplotype	NN	O	haplotype	nn	6	SENT_64	[p8l179t139r501b213],
6	map	NN	O	map	dep	3	SENT_64	[p8l528t158r667b213],
7	of	IN	O	of	_	0	SENT_64	[p8l696t139r772b198],
8	over	IN	O	over	quantmod	10	SENT_64	[p8l786t158r921b198],
9	3.1	CD	NUMBER	3.1	number	10	SENT_64	[p8l947t144r1041b198],
10	million	CD	NUMBER	million	num	11	SENT_64	[p8l1068t139r1308b198],
11	SNPs	NNS	O	snp	prep_of	6	SENT_64	[p8l1337t144r1519b198],
12	.	.	O	.	_	0	SENT_64	[p8l1337t144r1519b198],

1	Nature	NNP	O	Nature	_	0	SENT_65	[p8l1549t144r1772b198],
2	2007	CD	DATE	2007	num	1	SENT_65	[p8l1800t143r2110b209],
3	;	:	O	;	_	0	SENT_65	[p8l1800t143r2110b209],
4	449	CD	NUMBER	449	num	6	SENT_65	[p8l1800t143r2110b209],
5	:	:	O	:	_	0	SENT_65	[p8l1800t143r2110b209],
6	851-61	CD	NUMBER	851-61	dep	1	SENT_65	[p8l8t238r239b293],
7	.	.	O	.	_	0	SENT_65	[p8l8t238r239b293],

1	2	LS	NUMBER	2	_	0	SENT_66	[p8l7t335r59b386],
2	.	.	O	.	_	0	SENT_66	[p8l7t335r59b386],

1	Mailman	NNP	O	Mailman	nn	2	SENT_67	[p8l134t328r430b386],
2	MD	NNP	O	MD	_	0	SENT_67	[p8l460t333r594b399],
3	,	,	O	,	_	0	SENT_67	[p8l460t333r594b399],
4	Feolo	NNP	O	Feolo	nn	5	SENT_67	[p8l629t328r803b387],
5	M	NNP	O	M	appos	2	SENT_67	[p8l833t333r915b399],
6	,	,	O	,	_	0	SENT_67	[p8l833t333r915b399],
7	Jin	NNP	O	Jin	nn	8	SENT_67	[p8l943t329r1035b396],
8	Y	NN	O	y	appos	2	SENT_67	[p8l1064t333r1119b399],
9	,	,	O	,	_	0	SENT_67	[p8l1064t333r1119b399],
10	et	FW	O	et	nn	11	SENT_67	[p8l1155t341r1213b386],
11	al.	FW	O	al.	appos	2	SENT_67	[p8l1240t328r1314b387],
12	.	.	O	.	_	0	SENT_67	[p8l1240t328r1314b387],

1	The	DT	O	the	det	4	SENT_68	[p8l1347t328r1469b386],
2	NCBI	NN	O	ncbus	nn	4	SENT_68	[p8l1499t333r1671b387],
3	dbGaP	NN	O	dbgap	nn	4	SENT_68	[p8l1703t328r1920b387],
4	database	NN	O	database	_	0	SENT_68	[p8l1950t328r2112b387, p8l8t423r151b481],
5	of	IN	O	of	_	0	SENT_68	[p8l177t423r253b481],
6	genotypes	NNS	O	genotype	prep_of	4	SENT_68	[p8l264t435r595b498],
7	and	CC	O	and	_	0	SENT_68	[p8l622t423r741b481],
8	phenotypes	NNS	O	phenotype	prep_of	4	SENT_68	[p8l765t423r1161b497],
9	.	.	O	.	_	0	SENT_68	[p8l765t423r1161b497],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_69	[p8l1189t428r1306b482],
2	Genet	NNP	PERSON	Genet	_	0	SENT_69	[p8l1328t428r1523b481],
3	2007	CD	DATE	2007	num	2	SENT_69	[p8l1544t427r2053b493],
4	;	:	O	;	_	0	SENT_69	[p8l1544t427r2053b493],
5	39:1181	CD	NUMBER	39:1181	number	6	SENT_69	[p8l1544t427r2053b493],
6	—	CD	NUMBER	—	dep	2	SENT_69	[p8l1544t427r2053b493],
7	6	CD	NUMBER	6	dep	6	SENT_69	[p8l1544t427r2053b493],
8	.	.	O	.	_	0	SENT_69	[p8l1544t427r2053b493],

1	3	LS	NUMBER	3	_	0	SENT_70	[p8l8t524r59b575],
2	.	.	O	.	_	0	SENT_70	[p8l8t524r59b575],

1	Higashi	NNP	PERSON	Higashi	nn	2	SENT_71	[p8l135t517r391b592],
2	MK	NNP	O	MK	_	0	SENT_71	[p8l415t522r548b587],
3	,	,	O	,	_	0	SENT_71	[p8l415t522r548b587],
4	Veenstra	NNP	PERSON	Veenstra	nn	5	SENT_71	[p8l577t522r859b575],
5	DL	NNP	O	DL	appos	2	SENT_71	[p8l883t522r993b587],
6	,	,	O	,	_	0	SENT_71	[p8l883t522r993b587],
7	Kondo	NNP	PERSON	Kondo	nn	8	SENT_71	[p8l1025t517r1237b577],
8	LM	NNP	O	LM	appos	2	SENT_71	[p8l1264t522r1387b587],
9	,	,	O	,	_	0	SENT_71	[p8l1264t522r1387b587],
10	et	FW	O	et	nn	11	SENT_71	[p8l1419t529r1477b575],
11	al.	FW	O	al.	appos	2	SENT_71	[p8l1500t517r1574b575],
12	.	.	O	.	_	0	SENT_71	[p8l1500t517r1574b575],

1	Association	NNP	O	Association	nsubj	9	SENT_72	[p8l1603t518r1986b575],
2	between	IN	O	between	_	0	SENT_72	[p8l2013t517r2112b575, p8l8t623r202b670],
3	CYP2C9	NNP	O	CYP2C9	nn	5	SENT_72	[p8l227t615r482b669],
4	genetic	JJ	O	genetic	amod	5	SENT_72	[p8l507t612r742b686],
5	Variants	NNS	O	variant	prep_between	1	SENT_72	[p8l764t612r1025b670],
6	and	CC	O	and	_	0	SENT_72	[p8l1052t611r1171b669],
7	anticoagulation	NN	O	anticoagulation	nn	8	SENT_72	[p8l1195t611r1962b686],
8	—	NN	O	—	prep_between	1	SENT_72	[p8l1195t611r1962b686],
9	related	JJ	O	related	_	0	SENT_72	[p8l1195t611r1962b686],
10	outcomes	NNS	O	outcome	dobj	9	SENT_72	[p8l1989t623r2112b670, p8l8t724r212b763],
11	during	IN	O	during	_	0	SENT_72	[p8l240t705r459b780],
12	Warfarin	NN	O	warfarin	nn	13	SENT_72	[p8l479t705r763b764],
13	therapy	NN	O	therapy	prep_during	10	SENT_72	[p8l789t705r1044b779],
14	.	.	O	.	_	0	SENT_72	[p8l789t705r1044b779],

1	JAMA	NNP	O	JAMA	_	0	SENT_73	[p8l1067t710r1261b772],
2	2002	CD	DATE	2002	num	1	SENT_73	[p8l1285t709r1838b775],
3	;	:	O	;	_	0	SENT_73	[p8l1285t709r1838b775],
4	287:1690	CD	NUMBER	287:1690	number	5	SENT_73	[p8l1285t709r1838b775],
5	-8	CD	NUMBER	-8	dep	1	SENT_73	[p8l1285t709r1838b775],
6	.	.	O	.	_	0	SENT_73	[p8l1285t709r1838b775],

1	4	LS	NUMBER	4	_	0	SENT_74	[p8l6t806r59b857],
2	.	.	O	.	_	0	SENT_74	[p8l6t806r59b857],

1	Rieder	NNP	PERSON	Rieder	nn	2	SENT_75	[p8l135t799r344b860],
2	MJ	NNP	PERSON	MJ	_	0	SENT_75	[p8l365t804r467b869],
3	,	,	O	,	_	0	SENT_75	[p8l365t804r467b869],
4	Reiner	NNP	ORGANIZATION	Reiner	nn	5	SENT_75	[p8l495t800r706b860],
5	AP	NNP	ORGANIZATION	AP	appos	2	SENT_75	[p8l726t804r827b870],
6	,	,	O	,	_	0	SENT_75	[p8l726t804r827b870],
7	Gage	NNP	PERSON	Gage	nn	8	SENT_75	[p8l856t804r1019b874],
8	BF	NNP	O	BF	appos	2	SENT_75	[p8l1043t804r1138b870],
9	,	,	O	,	_	0	SENT_75	[p8l1043t804r1138b870],
10	et	FW	O	et	nn	11	SENT_75	[p8l1168t811r1225b857],
11	al.	FW	O	al.	appos	2	SENT_75	[p8l1246t799r1318b857],
12	.	.	O	.	_	0	SENT_75	[p8l1246t799r1318b857],

1	Effect	NN	O	effect	_	0	SENT_76	[p8l1347t799r1535b857],
2	of	IN	O	of	_	0	SENT_76	[p8l1557t799r1631b857],
3	VKORC1	NN	O	vkorc1	nn	4	SENT_76	[p8l1642t804r1882b858],
4	haplotypes	NNS	O	haplotype	prep_of	1	SENT_76	[p8l1910t799r2112b873, p8l66t1271r234b1333],

1	on	IN	O	on	_	0	SENT_77	[p8l262t1278r341b1317],
2	transcriptional	JJ	O	transcriptional	amod	3	SENT_77	[p8l367t1259r852b1333],
3	regulation	NN	O	regulation	pobj	1	SENT_77	[p8l877t1259r1213b1333],
4	and	CC	O	and	_	0	SENT_77	[p8l1239t1259r1357b1317],
5	Warfarin	NNP	O	Warfarin	nn	6	SENT_77	[p8l1379t1258r1660b1318],
6	dose	NN	O	dose	conj_and	3	SENT_77	[p8l1687t1259r1850b1317],
7	.	.	O	.	_	0	SENT_77	[p8l1687t1259r1850b1317],

1	N	NN	O	n	nn	2	SENT_78	[p8l1879t1264r1934b1317],
2	EnglJ	NN	O	englj	nsubj	3	SENT_78	[p8l1958t1259r2150b1333],
3	Med	VBD	O	med	_	0	SENT_78	[p8l64t1353r202b1410],
4	2005	CD	DATE	2005	dobj	3	SENT_78	[p8l228t1357r814b1423],
5	;	:	O	;	_	0	SENT_78	[p8l228t1357r814b1423],
6	352:2285	CD	NUMBER	352:2285	num	7	SENT_78	[p8l228t1357r814b1423],
7	-93	CD	NUMBER	-93	dep	4	SENT_78	[p8l228t1357r814b1423],
8	.	.	O	.	_	0	SENT_78	[p8l228t1357r814b1423],

1	5	CD	NUMBER	5	_	0	SENT_79	[p8l66t1454r116b1505],
2	.	.	O	.	_	0	SENT_79	[p8l66t1454r116b1505],

1	FDA	NNP	ORGANIZATION	FDA	nsubj	2	SENT_80	[p8l191t1452r329b1505],
2	approves	VBZ	O	approve	_	0	SENT_80	[p8l353t1466r636b1521],
3	updated	VBN	O	update	amod	4	SENT_80	[p8l664t1447r923b1521],
4	warfarin	NN	O	warfarin	dobj	2	SENT_80	[p8l947t1446r1228b1505],
5	(	CD	NUMBER	(	num	6	SENT_80	[p8l1259t1447r1636b1514],
6	Coumadin	NNP	O	Coumadin	dep	2	SENT_80	[p8l1259t1447r1636b1514],
7	)	CD	NUMBER	)	num	6	SENT_80	[p8l1259t1447r1636b1514],
8	prescribing	VBG	O	prescribe	partmod	6	SENT_80	[p8l1666t1447r2037b1521],
9	information	NN	O	information	dobj	8	SENT_80	[p8l2061t1447r2147b1504, p8l65t1540r409b1599],
10	.	.	O	.	_	0	SENT_80	[p8l2061t1447r2147b1504, p8l65t1540r409b1599],

1	Press	NNP	O	Press	nn	2	SENT_81	[p8l440t1546r607b1599],
2	release	NN	O	release	_	0	SENT_81	[p8l637t1541r857b1599],
3	of	IN	O	of	_	0	SENT_81	[p8l887t1540r961b1599],
4	the	DT	O	the	det	8	SENT_81	[p8l977t1541r1076b1599],
5	Food	NNP	ORGANIZATION	Food	nn	8	SENT_81	[p8l1103t1541r1264b1599],
6	and	CC	ORGANIZATION	and	_	0	SENT_81	[p8l1292t1541r1410b1599],
7	Drug	NNP	ORGANIZATION	Drug	conj_and	5	SENT_81	[p8l1437t1546r1602b1615],
8	Administration	NNP	ORGANIZATION	Administration	prep_of	2	SENT_81	[p8l1626t1541r2144b1611],
9	,	,	O	,	_	0	SENT_81	[p8l1626t1541r2144b1611],
10	Rockville	NNP	LOCATION	Rockville	appos	2	SENT_81	[p8l65t1635r385b1704],
11	,	,	O	,	_	0	SENT_81	[p8l65t1635r385b1704],
12	MD	NNP	O	MD	nn	14	SENT_81	[p8l410t1640r543b1704],
13	,	,	O	,	_	0	SENT_81	[p8l410t1640r543b1704],
14	August	NNP	DATE	August	appos	2	SENT_81	[p8l568t1640r800b1708],
15	16	CD	DATE	16	num	14	SENT_81	[p8l822t1639r910b1704],
16	,	,	DATE	,	_	0	SENT_81	[p8l822t1639r910b1704],
17	2007	CD	DATE	2007	num	14	SENT_81	[p8l938t1639r1102b1692],
18	.	.	O	.	_	0	SENT_81	[p8l938t1639r1102b1692],

1	(	NN	O	(	nsubj	2	SENT_82	[p8l1133t1635r1444b1701],
2	Accessed	VBD	O	access	_	0	SENT_82	[p8l1133t1635r1444b1701],
3	February	NNP	DATE	February	dobj	2	SENT_82	[p8l1466t1635r1756b1708],
4	14	CD	DATE	14	num	3	SENT_82	[p8l1779t1639r1865b1704],
5	,	,	DATE	,	_	0	SENT_82	[p8l1779t1639r1865b1704],
6	2008	CD	DATE	2008	num	3	SENT_82	[p8l1892t1639r2066b1704],
7	,	,	O	,	_	0	SENT_82	[p8l1892t1639r2066b1704],
8	at	IN	O	at	dep	3	SENT_82	[p8l2093t1647r2152b1692],
9	http://WWW.fda.gov/bbs/topics/NEWS/2007/NEW01684.html	NN	O	http://www.fda.gov/bbs/topics/news/2007/new01684.html	pobj	8	SENT_82	[p8l66t1727r2051b1802],
10	.	.	O	.	_	0	SENT_82	[p8l66t1727r2051b1802],
11	)	SYM	O	)	dep	3	SENT_82	[p8l66t1727r2051b1802],

1	6	CD	NUMBER	6	_	0	SENT_83	[p8l66t1828r116b1880],
2	.	.	O	.	_	0	SENT_83	[p8l66t1828r116b1880],

1	Schwarz	NNP	PERSON	Schwarz	nn	2	SENT_84	[p8l194t1822r461b1880],
2	UI	NNP	O	UI	_	0	SENT_84	[p8l487t1827r581b1892],
3	,	,	O	,	_	0	SENT_84	[p8l487t1827r581b1892],
4	Ritchie	NNP	PERSON	Ritchie	nn	5	SENT_84	[p8l610t1822r839b1883],
5	MD	NNP	O	MD	appos	2	SENT_84	[p8l863t1827r996b1892],
6	,	,	O	,	_	0	SENT_84	[p8l863t1827r996b1892],
7	Bradford	NNP	ORGANIZATION	Bradford	nn	8	SENT_84	[p8l1025t1821r1310b1880],
8	Y	NN	ORGANIZATION	y	appos	2	SENT_84	[p8l1333t1827r1387b1892],
9	,	,	O	,	_	0	SENT_84	[p8l1333t1827r1387b1892],
10	et	FW	O	et	nn	11	SENT_84	[p8l1417t1834r1475b1879],
11	al.	FW	O	al.	appos	2	SENT_84	[p8l1497t1822r1570b1880],
12	.	.	O	.	_	0	SENT_84	[p8l1497t1822r1570b1880],

1	Genetic	JJ	O	genetic	amod	2	SENT_85	[p8l1600t1822r1847b1880],
2	determinants	NNS	O	determinant	_	0	SENT_85	[p8l1874t1822r2147b1880, p8l66t1928r242b1974],
3	of	IN	O	of	_	0	SENT_85	[p8l284t1915r359b1974],
4	response	NN	O	response	prep_of	2	SENT_85	[p8l384t1935r670b1990],
5	to	TO	O	to	_	0	SENT_85	[p8l710t1928r771b1974],
6	Warfarin	NNP	MISC	Warfarin	prep_to	2	SENT_85	[p8l808t1915r1090b1975],
7	during	IN	O	during	_	0	SENT_85	[p8l1129t1916r1346b1990],
8	initial	JJ	O	initial	amod	9	SENT_85	[p8l1383t1916r1577b1974],
9	anticoagulation	NN	O	anticoagulation	prep_during	2	SENT_85	[p8l1615t1916r2144b1990],
10	.	.	O	.	_	0	SENT_85	[p8l1615t1916r2144b1990],

1	N	NN	O	n	nn	2	SENT_86	[p8l64t2015r120b2067],
2	EnglJ	NN	O	englj	nsubj	3	SENT_86	[p8l142t2010r334b2083],
3	Med	VBD	O	med	_	0	SENT_86	[p8l355t2010r494b2067],
4	2008	CD	DATE	2008	dobj	3	SENT_86	[p8l519t2014r1147b2079],
5	;	:	O	;	_	0	SENT_86	[p8l519t2014r1147b2079],
6	358:999	CD	NUMBER	358:999	num	7	SENT_86	[p8l519t2014r1147b2079],
7	-1008	CD	NUMBER	-1008	dep	4	SENT_86	[p8l519t2014r1147b2079],
8	.	.	O	.	_	0	SENT_86	[p8l519t2014r1147b2079],

1	7	CD	NUMBER	7	_	0	SENT_87	[p8l67t2110r116b2160],
2	.	.	O	.	_	0	SENT_87	[p8l67t2110r116b2160],

1	Gage	NNP	PERSON	Gage	nn	2	SENT_88	[p8l193t2107r355b2176],
2	BF	NNP	O	BF	_	0	SENT_88	[p8l379t2108r474b2172],
3	,	,	O	,	_	0	SENT_88	[p8l379t2108r474b2172],
4	Eby	NNP	PERSON	Eby	nn	5	SENT_88	[p8l501t2103r617b2176],
5	C	NNP	O	C	appos	2	SENT_88	[p8l638t2107r700b2172],
6	,	,	O	,	_	0	SENT_88	[p8l638t2107r700b2172],
7	Milligan	NNP	PERSON	Milligan	nn	8	SENT_88	[p8l726t2103r1002b2176],
8	PE	NNP	O	PE	appos	5	SENT_88	[p8l1025t2108r1122b2172],
9	,	,	O	,	_	0	SENT_88	[p8l1025t2108r1122b2172],
10	Banet	NNP	ORGANIZATION	Banet	nn	11	SENT_88	[p8l1149t2108r1335b2160],
11	GA	NNP	ORGANIZATION	GA	appos	5	SENT_88	[p8l1355t2107r1474b2172],
12	,	,	O	,	_	0	SENT_88	[p8l1355t2107r1474b2172],
13	Duncan	NNP	PERSON	Duncan	nn	14	SENT_88	[p8l1501t2108r1754b2161],
14	JR	NNP	O	JR	appos	5	SENT_88	[p8l1770t2108r1866b2172],
15	,	,	O	,	_	0	SENT_88	[p8l1770t2108r1866b2172],
16	McLeod	NNP	PERSON	McLeod	nn	17	SENT_88	[p8l1892t2103r2148b2160],
17	HL	NNS	O	hl	appos	5	SENT_88	[p8l65t2201r179b2254],
18	.	.	O	.	_	0	SENT_88	[p8l65t2201r179b2254],

1	Use	NN	O	use	_	0	SENT_89	[p8l209t2201r325b2254],
2	of	IN	O	of	_	0	SENT_89	[p8l352t2195r426b2254],
3	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	1	SENT_89	[p8l438t2196r1032b2270],
4	and	CC	O	and	_	0	SENT_89	[p8l1059t2196r1177b2254],
5	clinical	JJ	O	clinical	amod	6	SENT_89	[p8l1203t2196r1439b2254],
6	factors	NNS	O	factor	prep_of	1	SENT_89	[p8l1464t2195r1683b2254],
7	to	TO	O	to	aux	8	SENT_89	[p8l1711t2208r1772b2254],
8	predict	VB	O	predict	infmod	1	SENT_89	[p8l1798t2196r2026b2270],
9	the	DT	O	the	det	11	SENT_89	[p8l2049t2196r2148b2254],
10	maintenance	NN	O	maintenance	nn	11	SENT_89	[p8l66t2290r480b2347],
11	dose	NN	O	dose	dobj	8	SENT_89	[p8l505t2290r650b2348],
12	of	IN	O	of	_	0	SENT_89	[p8l675t2289r749b2348],
13	Warfarin	NNP	O	Warfarin	prep_of	11	SENT_89	[p8l757t2289r1052b2348],
14	.	.	O	.	_	0	SENT_89	[p8l757t2289r1052b2348],

1	Thromb	NNP	O	Thromb	nn	2	SENT_90	[p8l1078t2290r1338b2348],
2	Haemost	NNP	O	Haemost	_	0	SENT_90	[p8l1363t2295r1652b2348],
3	2004	CD	DATE	2004	num	2	SENT_90	[p8l1673t2294r2138b2360],
4	;	:	O	;	_	0	SENT_90	[p8l1673t2294r2138b2360],
5	91:87	CD	NUMBER	91:87	number	6	SENT_90	[p8l1673t2294r2138b2360],
6	—	CD	NUMBER	—	dep	2	SENT_90	[p8l1673t2294r2138b2360],
7	94	CD	NUMBER	94	dep	6	SENT_90	[p8l1673t2294r2138b2360],
8	.	.	O	.	_	0	SENT_90	[p8l1673t2294r2138b2360],

1	8	CD	NUMBER	8	_	0	SENT_91	[p8l65t2389r116b2442],
2	.	.	O	.	_	0	SENT_91	[p8l65t2389r116b2442],

1	Department	NNP	ORGANIZATION	Department	_	0	SENT_92	[p8l191t2389r584b2458],
2	of	IN	ORGANIZATION	of	_	0	SENT_92	[p8l619t2383r693b2442],
3	Health	NNP	ORGANIZATION	Health	nn	6	SENT_92	[p8l716t2384r934b2442],
4	and	CC	ORGANIZATION	and	_	0	SENT_92	[p8l971t2384r1089b2442],
5	Human	NNP	ORGANIZATION	Human	nn	6	SENT_92	[p8l1126t2389r1368b2442],
6	Services	NNPS	ORGANIZATION	Services	prep_of	1	SENT_92	[p8l1407t2384r1682b2443],
7	.	.	O	.	_	0	SENT_92	[p8l1407t2384r1682b2443],

1	Business	NN	O	business	nn	2	SENT_93	[p8l1723t2384r2004b2442],
2	opportunities	NNS	O	opportunity	_	0	SENT_93	[p8l2043t2403r2147b2458, p8l65t2478r444b2552],
3	.	.	O	.	_	0	SENT_93	[p8l2043t2403r2147b2458, p8l65t2478r444b2552],

1	(	NN	O	(	nsubj	2	SENT_94	[p8l494t2478r805b2545],
2	Accessed	VBD	O	access	_	0	SENT_94	[p8l494t2478r805b2545],
3	February	NNP	DATE	February	tmod	2	SENT_94	[p8l846t2478r1136b2552],
4	14	CD	DATE	14	num	3	SENT_94	[p8l1177t2482r1263b2548],
5	,	,	DATE	,	_	0	SENT_94	[p8l1177t2482r1263b2548],
6	2008	CD	DATE	2008	num	3	SENT_94	[p8l1310t2482r1484b2548],
7	,	,	O	,	_	0	SENT_94	[p8l1310t2482r1484b2548],
8	at	IN	O	at	_	0	SENT_94	[p8l1530t2490r1588b2536],
9	http://wWW.fbo	NN	O	http://www.fbo	prep_at	2	SENT_94	[p8l1627t2477r2144b2552],
10	.	.	O	.	_	0	SENT_94	[p8l1627t2477r2144b2552],

1	gov/servlet/Solicitation	NN	O	gov/servlet/solicitation	_	0	SENT_95	[p8l65t2572r2096b2645],
2	/	:	O	/	punct	3	SENT_95	[p8l65t2572r2096b2645],
3	R/HHS/NIH	NN	O	r/hhs/nih	dep	1	SENT_95	[p8l65t2572r2096b2645],
4	/	:	O	/	punct	3	SENT_95	[p8l65t2572r2096b2645],
5	NHLBI/NHLBI-HV	NN	O	nhlbi/nhlbi-hv	dep	1	SENT_95	[p8l65t2572r2096b2645],
6	-08	CD	NUMBER	-08	rcmod	5	SENT_95	[p8l65t2572r2096b2645],
7	-03	CD	NUMBER	-03	rcmod	6	SENT_95	[p8l65t2572r2096b2645],
8	.	.	O	.	_	0	SENT_95	[p8l65t2572r2096b2645],
9	)	SYM	O	)	dep	6	SENT_95	[p8l65t2572r2096b2645],

1	9	CD	NUMBER	9	_	0	SENT_96	[p8l65t2671r116b2723],
2	.	.	O	.	_	0	SENT_96	[p8l65t2671r116b2723],

1	Takahashi	NNP	PERSON	Takahashi	nn	2	SENT_97	[p8l190t2665r526b2724],
2	H	NNP	O	H	_	0	SENT_97	[p8l561t2670r633b2735],
3	,	,	O	,	_	0	SENT_97	[p8l561t2670r633b2735],
4	Wilkinson	NNP	PERSON	Wilkinson	nn	5	SENT_97	[p8l671t2665r1011b2724],
5	GR	NN	O	gr	appos	2	SENT_97	[p8l1048t2669r1167b2735],
6	,	,	O	,	_	0	SENT_97	[p8l1048t2669r1167b2735],
7	Nutescu	NNP	ORGANIZATION	Nutescu	nn	8	SENT_97	[p8l1206t2670r1468b2723],
8	EA	NN	ORGANIZATION	ea	appos	2	SENT_97	[p8l1503t2670r1611b2735],
9	,	,	O	,	_	0	SENT_97	[p8l1503t2670r1611b2735],
10	et	FW	O	et	nn	11	SENT_97	[p8l1652t2677r1710b2722],
11	al.	FW	O	al.	appos	2	SENT_97	[p8l1743t2665r1816b2723],
12	.	.	O	.	_	0	SENT_97	[p8l1743t2665r1816b2723],

1	Different	JJ	O	different	amod	2	SENT_98	[p8l1856t2664r2152b2722],
2	contributions	NNS	O	contribution	_	0	SENT_98	[p8l66t2759r493b2817],
3	of	IN	O	of	_	0	SENT_98	[p8l515t2758r589b2817],
4	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_98	[p8l594t2759r1093b2833],
5	in	IN	O	in	_	0	SENT_98	[p8l1115t2759r1176b2816],
6	VKORC1	NN	O	vkorc1	prep_in	4	SENT_98	[p8l1193t2763r1468b2820],
7	and	CC	O	and	_	0	SENT_98	[p8l1488t2759r1605b2817],
8	CYPZC9	NN	O	cypzc9	prep_in	4	SENT_98	[p8l1624t2763r1873b2817],
9	to	TO	O	to	_	0	SENT_98	[p8l1894t2771r1954b2817],
10	intraand	JJ	O	intraand	amod	12	SENT_98	[p8l1974t2759r2147b2817, p8l65t2853r184b2911],
11	inter-population	NN	O	inter-population	nn	12	SENT_98	[p8l214t2853r757b2927],
12	differences	NNS	O	difference	prep_to	2	SENT_98	[p8l787t2852r1153b2911],
13	in	IN	O	in	_	0	SENT_98	[p8l1184t2853r1248b2910],
14	maintenance	NN	O	maintenance	nn	15	SENT_98	[p8l1277t2853r1703b2911],
15	dose	NN	O	dose	prep_in	2	SENT_98	[p8l1734t2853r1882b2911],
16	of	IN	O	of	_	0	SENT_98	[p8l1913t2852r1989b2911],
17	warfarin	NN	O	warfarin	prep_of	15	SENT_98	[p8l2001t2872r2147b2912, p8l65t2946r225b3005],
18	in	IN	O	in	_	0	SENT_98	[p8l253t2947r316b3004],
19	Japanese	JJ	MISC	japanese	prep_in	17	SENT_98	[p8l338t2952r642b3021],
20	,	,	O	,	_	0	SENT_98	[p8l338t2952r642b3021],
21	Caucasians	NNPS	MISC	Caucasians	conj_and	19	SENT_98	[p8l675t2947r1034b3006],
22	and	CC	O	and	_	0	SENT_98	[p8l1064t2947r1182b3005],
23	African	NNP	MISC	African	conj_and	19	SENT_98	[p8l1208t2946r1841b3005],
24	.	.	O	.	_	0	SENT_98	[p8l1208t2946r1841b3005],

1	—	NN	O	—	_	0	SENT_99	[p8l1208t2946r1841b3005],
2	.	.	O	.	_	0	SENT_99	[p8l1208t2946r1841b3005],

1	Americans	NNPS	MISC	Americans	_	0	SENT_100	[p8l1208t2946r1841b3005],
2	.	.	O	.	_	0	SENT_100	[p8l1208t2946r1841b3005],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_101	[p8l1874t2947r2147b3005, p8l66t3053r318b3114],
2	Genomics	NNP	O	Genomics	_	0	SENT_101	[p8l340t3041r664b3098],
3	2006	CD	DATE	2006	num	2	SENT_101	[p8l691t3045r1188b3110],
4	;	:	O	;	_	0	SENT_101	[p8l691t3045r1188b3110],
5	16:101	CD	NUMBER	16:101	number	6	SENT_101	[p8l691t3045r1188b3110],
6	-10	CD	NUMBER	-10	dep	2	SENT_101	[p8l691t3045r1188b3110],
7	.	.	O	.	_	0	SENT_101	[p8l691t3045r1188b3110],

1	Copyright	NN	O	copyright	_	0	SENT_102	[p8l68t3144r316b3207],
2	©	CD	NUMBER	©	num	6	SENT_102	[p8l339t3149r392b3202],
3	2008	CD	DATE	2008	num	6	SENT_102	[p8l418t3148r550b3192],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_102	[p8l572t3144r946b3192],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_102	[p8l969t3144r1173b3192],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_102	[p8l1193t3146r1386b3206],
7	.	.	O	.	_	0	SENT_102	[p8l1193t3146r1386b3206],

1	JOURNAL	NN	O	journal	_	0	SENT_103	[p9l679t147r811b173],
2	EDITORIAL	NN	O	editorial	nn	3	SENT_103	[p9l828t147r973b167],
3	FELLOW	NN	O	fellow	dep	1	SENT_103	[p9l988t147r1097b167],

1	The	DT	O	the	det	2	SENT_104	[p9l447t189r625b222],
2	]	NN	O	]	poss	6	SENT_104	[p9l447t189r625b222],
3	ournal	JJ	O	ournal	amod	2	SENT_104	[p9l447t189r625b222],
4	’s	POS	O	’s	_	0	SENT_104	[p9l447t189r625b222],
5	editorial	NN	O	editorial	nn	6	SENT_104	[p9l636t189r754b215],
6	office	NN	O	office	nsubj	7	SENT_104	[p9l764t189r843b215],
7	invites	VBZ	O	invite	_	0	SENT_104	[p9l853t189r944b215],
8	applications	NNS	O	application	dobj	7	SENT_104	[p9l954t189r1128b222],
9	for	IN	O	for	_	0	SENT_104	[p9l1139t189r1180b215],
10	a	DT	O	a	det	14	SENT_104	[p9l1189t197r1203b215],
11	one-year	JJ	DURATION	one-year	amod	14	SENT_104	[p9l1213t197r1335b222],
12	research	NN	O	research	nn	14	SENT_104	[p9l417t233r537b259],
13	fellowship	NN	O	fellowship	nn	14	SENT_104	[p9l546t232r695b266],
14	beginning	NN	DATE	beginning	prep_for	8	SENT_104	[p9l705t233r852b266],
15	in	IN	DATE	in	_	0	SENT_104	[p9l860t233r888b258],
16	July	NNP	DATE	July	prep_in	14	SENT_104	[p9l894t233r950b266],
17	2009	CD	DATE	2009	num	16	SENT_104	[p9l958t235r1027b259],
18	from	IN	O	from	_	0	SENT_104	[p9l1037t232r1107b259],
19	individuals	NNS	O	individual	prep_from	7	SENT_104	[p9l1116t233r1272b259],
20	at	IN	O	at	_	0	SENT_104	[p9l1282t238r1309b259],
21	any	DT	O	any	det	22	SENT_104	[p9l1317t241r1366b266],
22	stage	NN	O	stage	prep_at	19	SENT_104	[p9l420t282r493b310],
23	of	IN	O	of	_	0	SENT_104	[p9l503t276r536b302],
24	training	NN	O	training	prep_of	22	SENT_104	[p9l540t277r661b310],
25	.	.	O	.	_	0	SENT_104	[p9l540t277r661b310],

1	The	DT	O	the	det	3	SENT_105	[p9l672t276r726b302],
2	editorial	NN	O	editorial	nn	3	SENT_105	[p9l736t276r854b302],
3	fellow	NN	O	fellow	nsubjpass	23	SENT_105	[p9l864t276r952b303],
4	will	MD	O	will	aux	5	SENT_105	[p9l959t276r1012b303],
5	work	VB	O	work	_	0	SENT_105	[p9l1020t276r1095b303],
6	on	IN	O	on	_	0	SENT_105	[p9l1103t285r1139b302],
7	journal	NN	O	journal	nn	8	SENT_105	[p9l1144t276r1240b310],
8	projects	NNS	O	project	prep_on	5	SENT_105	[p9l1250t277r1362b310],
9	and	CC	O	and	_	0	SENT_105	[p9l403t320r455b346],
10	will	MD	O	will	aux	11	SENT_105	[p9l463t320r516b346],
11	participate	VB	O	participate	conj_and	5	SENT_105	[p9l525t321r677b354],
12	in	IN	O	in	_	0	SENT_105	[p9l686t321r714b346],
13	the	DT	O	the	det	16	SENT_105	[p9l724t320r767b346],
14	day-to	JJ	O	day-to	amod	16	SENT_105	[p9l777t320r926b353],
15	—	NN	O	—	nn	16	SENT_105	[p9l777t320r926b353],
16	day	NN	DURATION	day	prep_in	11	SENT_105	[p9l777t320r926b353],
17	editorial	NN	O	editorial	nn	18	SENT_105	[p9l935t320r1053b346],
18	activities	NNS	O	activity	dobj	11	SENT_105	[p9l1063t321r1186b347],
19	of	IN	O	of	_	0	SENT_105	[p9l1197t320r1230b346],
20	thejoumal	JJ	O	thejoumal	prep_of	18	SENT_105	[p9l1234t320r1379b354],
21	but	CC	O	but	_	0	SENT_105	[p9l446t364r493b390],
22	is	VBZ	O	be	auxpass	23	SENT_105	[p9l501t364r523b390],
23	expected	VBN	O	expect	conj_but	5	SENT_105	[p9l533t364r657b397],
24	in	IN	O	in	_	0	SENT_105	[p9l667t364r694b390],
25	addition	NN	O	addition	prep_in	23	SENT_105	[p9l703t364r822b390],
26	to	TO	O	to	aux	27	SENT_105	[p9l832t370r858b390],
27	have	VB	O	have	xcomp	23	SENT_105	[p9l869t364r932b390],
28	his	PRP$	O	he	amod	33	SENT_105	[p9l942t364r983b390],
29	or	CC	O	or	_	0	SENT_105	[p9l994t372r1023b390],
30	her	PRP$	O	she	amod	33	SENT_105	[p9l1032t364r1079b390],
31	own	JJ	O	own	amod	33	SENT_105	[p9l1088t372r1148b390],
32	independent	JJ	O	independent	amod	33	SENT_105	[p9l1158t364r1338b397],
33	projects	NNS	O	project	dobj	27	SENT_105	[p9l461t408r582b441],
34	.	.	O	.	_	0	SENT_105	[p9l461t408r582b441],

1	Please	VB	O	please	dep	2	SENT_106	[p9l593t408r681b434],
2	send	VB	O	send	_	0	SENT_106	[p9l691t408r757b434],
3	curriculum	NN	O	curriculum	nn	4	SENT_106	[p9l767t408r924b434],
4	vitae	NNS	O	vita	dobj	2	SENT_106	[p9l932t408r998b434],
5	and	CC	O	and	_	0	SENT_106	[p9l1008t408r1060b434],
6	research	NN	O	research	nn	7	SENT_106	[p9l1070t408r1189b434],
7	interests	NNS	O	interest	dobj	2	SENT_106	[p9l1199t408r1319b434],
8	to	TO	O	to	_	0	SENT_106	[p9l478t457r505b478],
9	the	DT	O	the	det	10	SENT_106	[p9l515t452r559b478],
10	Editor	NNP	O	Editor	prep_to	2	SENT_106	[p9l568t451r793b483],
11	.	.	O	.	_	0	SENT_106	[p9l568t451r793b483],

1	—	NN	O	—	_	0	SENT_107	[p9l568t451r793b483],
2	.	.	O	.	_	0	SENT_107	[p9l568t451r793b483],

1	in	IN	O	in	_	0	SENT_108	[p9l568t451r793b483],
2	.	.	O	.	_	0	SENT_108	[p9l568t451r793b483],

1	—	NN	O	—	_	0	SENT_109	[p9l568t451r793b483],
2	.	.	O	.	_	0	SENT_109	[p9l568t451r793b483],

1	Chief	NNP	O	Chief	_	0	SENT_110	[p9l568t451r793b483],
2	,	,	O	,	_	0	SENT_110	[p9l568t451r793b483],
3	10	CD	NUMBER	10	appos	1	SENT_110	[p9l806t454r839b478],
4	Shattuck	NNP	PERSON	Shattuck	nn	9	SENT_110	[p9l849t452r974b478],
5	St.	NNP	PERSON	St.	nn	9	SENT_110	[p9l983t454r1027b483],
6	,	,	O	,	_	0	SENT_110	[p9l983t454r1027b483],
7	Boston	NNP	LOCATION	Boston	appos	9	SENT_110	[p9l1038t454r1146b483],
8	,	,	O	,	_	0	SENT_110	[p9l1038t454r1146b483],
9	MA	NNP	O	MA	dep	1	SENT_110	[p9l1157t454r1208b477],
10	02115	CD	DATE	02115	num	9	SENT_110	[p9l1217t454r1302b478],

1	(	NN	O	(	nn	2	SENT_111	[p9l573t495r632b527],
2	fax	NN	O	fax	_	0	SENT_111	[p9l573t495r632b527],
3	,	,	O	,	_	0	SENT_111	[p9l573t495r632b527],
4	617-739-9864	CD	NUMBER	617-739-9864	num	5	SENT_111	[p9l644t497r863b527],
5	)	NN	O	)	appos	2	SENT_111	[p9l644t497r863b527],
6	,	,	O	,	_	0	SENT_111	[p9l644t497r863b527],
7	by	IN	O	by	_	0	SENT_111	[p9l875t495r907b529],
8	September	NNP	DATE	September	prep_by	2	SENT_111	[p9l917t496r1069b529],
9	30	CD	DATE	30	num	8	SENT_111	[p9l1078t497r1120b527],
10	,	,	DATE	,	_	0	SENT_111	[p9l1078t497r1120b527],
11	2008	CD	DATE	2008	num	8	SENT_111	[p9l1132t497r1209b522],
12	.	.	O	.	_	0	SENT_111	[p9l1132t497r1209b522],

1	N	NN	O	n	nn	3	SENT_112	[p9l525t656r539b671],
2	ENGLJ	NN	O	englj	nn	3	SENT_112	[p9l553t656r631b678],
3	MED	NN	O	med	_	0	SENT_112	[p9l646t656r698b671],
4	358	CD	NUMBER	358	num	6	SENT_112	[p9l708t650r785b678],
5	;	:	O	;	_	0	SENT_112	[p9l708t650r785b678],
6	1o	CD	NUMBER	1o	dep	3	SENT_112	[p9l708t650r785b678],
7	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	8	SENT_112	[p9l818t656r1019b678],
8	MARCH	NNP	DATE	MARCH	dep	3	SENT_112	[p9l1056t656r1141b671],
9	6,2008	CD	DATE	6,2008	number	10	SENT_112	[p9l1154t650r1249b676],
10	1063	CD	DATE	1063	dep	8	SENT_112	[p9l1940t645r2015b669],

